var title_f33_34_34336="Aortogram coarctation of the aorta 3 sign";
var content_f33_34_34336=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F87858&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F87858&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aortogram coarctation showing aorta \"3\" sign",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 333px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The aortogram shows the \"3\" sign consisting of&nbsp; the enlarged and distorted aortic knob and subclavian artery forming the upper portion of the 3, the waist at the site of the coarctation (arrow), and the lower portion formed by the post stenotic dilatation of the proximal descending aorta.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34336=[""].join("\n");
var outline_f33_34_34336=null;
var title_f33_34_34337="Calculator: Adult burn injury fluid resuscitation (Parkland crystalloid estimate)";
var content_f33_34_34337=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"BurnInjuryFluidParkland_form\" name=\"BurnInjuryFluidParkland_form\" onkeydown=\"clrResults();\" onkeyup=\"BurnInjuryFluidParkland_fx();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: Adult burn injury fluid resuscitation (Parkland crystalloid estimate)",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <center>",
"     <div id=\"calc_equation\">",
"      <table cellpadding=\"10\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"       <tr>",
"        <td align=\"left\" bgcolor=\"#6c9a9c\">",
"         <span class=\"medCalcFontFormuli\">",
"          TotalCrystalloidForFirst24Hours = 4 * Weight * PercentNonsuperficialBurnArea",
"         </span>",
"        </td>",
"       </tr>",
"      </table>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"     </div>",
"    </center>",
"    <div id=\"calc_main\">",
"     <center>",
"      <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"       <tr>",
"        <td align=\"right\" width=\"50%\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Input:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Weight",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Weight_param\" onblur=\"BurnInjuryFluidParkland_fx(); minMaxCheck();\" onchange=\"BurnInjuryFluidParkland_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Weight_unit\" onchange=\"BurnInjuryFluidParkland_fx();\" style=\"width:105px;\">",
"              <option selected=\"selected\" value=\"1|0|kg\">",
"               kg",
"              </option>",
"              <option value=\"0.45359237|0|lb\">",
"               lb",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Percent Nonsuperficial Burn Area",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Percent_Nonsuperficial_Burn_Area_param\" onblur=\"BurnInjuryFluidParkland_fx(); minMaxCheck();\" onchange=\"BurnInjuryFluidParkland_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <span style=\"white-space: nowrap;\">",
"              <span class=\"medCalcFontOneBold\">",
"               Percent",
"              </span>",
"             </span>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"        </td>",
"        <td align=\"left\" bgcolor=\"#eeeeee\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Results:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Total Crystalloid For First 24 Hours",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Total_Crystalloid_For_First_24_Hours_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"            <td valign=\"top\">",
"             <span class=\"medCalcFontOne\">",
"              <select class=\"medCalcFontSelect\" name=\"Total_Crystalloid_For_First_24_Hours_unit\" onchange=\"BurnInjuryFluidParkland_fx();\" style=\"width:105px;\">",
"               <option value=\"1000|0|L\">",
"                L",
"               </option>",
"               <option selected=\"selected\" value=\"1|0|mL\">",
"                mL",
"               </option>",
"              </select>",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"2\">",
"             &nbsp;",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Rate First 8 Hours",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Rate_First_8_Hours_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"            <td valign=\"top\">",
"             <span class=\"medCalcFontOne\">",
"              <select class=\"medCalcFontSelect\" name=\"Rate_First_8_Hours_unit\" onchange=\"BurnInjuryFluidParkland_fx();\" style=\"width:105px;\">",
"               <option value=\"999.99999982|0|L/hr\">",
"                L/hr",
"               </option>",
"               <option selected=\"selected\" value=\"1|0|mL/hr\">",
"                mL/hr",
"               </option>",
"               <option value=\"59.999999988|0|mL/min\">",
"                mL/min",
"               </option>",
"              </select>",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Rate Next 16 Hours",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Rate_Next_16_Hours_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"            <td valign=\"top\">",
"             <span class=\"medCalcFontOne\">",
"              <select class=\"medCalcFontSelect\" name=\"Rate_Next_16_Hours_unit\" onchange=\"BurnInjuryFluidParkland_fx();\" style=\"width:105px;\">",
"               <option value=\"999.99999982|0|L/hr\">",
"                L/hr",
"               </option>",
"               <option selected=\"selected\" value=\"1|0|mL/hr\">",
"                mL/hr",
"               </option>",
"               <option value=\"59.999999988|0|mL/min\">",
"                mL/min",
"               </option>",
"              </select>",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"3\">",
"             &nbsp;",
"             <br/>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <center>",
"          <span class=\"medCalcFontOne\">",
"           <input name=\"reset\" type=\"reset\" value=\"Reset form\"/>",
"          </span>",
"         </center>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <span class=\"medCalcFontOneBold\">",
"      Notes",
"     </span>",
"     <ul class=\"medCalcFontOne\">",
"      <li>",
"       Fluid needs calculated according to the Parkland formula provide only a guide to baseline fluid requirements in patients with major burns. Superficial burns are not included in the calculation.",
"      </li>",
"      <li>",
"       Patients with burn shock require immediate, aggressive IV fluid resuscitation and their fluid needs can exceed those estimated by the Parkland formula.",
"      </li>",
"      <li>",
"       The fluid needs of burn patients vary widely. Use physiologic parameters (e.g. blood pressure, pulse, urine output) to determine the adequacy of fluid resuscitation.",
"      </li>",
"      <li>",
"       Children with major burns have additional fluid needs.",
"      </li>",
"     </ul>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Saffle, JR. Practice guidelines for burn care.",
"        <i>",
"         J Burn Care",
"        </i>",
"        . 2001; 22(Suppl):i.",
"       </span>",
"      </li>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Slater H, Goldfarb IW. The management of burn trauma: a house staff handbook.",
"        <i>",
"         Western Pennsylvania Hospital",
"        </i>",
"        . 2003: p 9-12.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34337=[" ",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"var currenttimeout;",
"",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function BurnInjuryFluidParkland_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 3000);",
"",
"with(document.BurnInjuryFluidParkland_form){",
"",
"",
"doCalc = true;",
"if (Weight_param.value.indexOf(',') >= 0){ Weight_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Weight_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Weight_unit.options[Weight_unit.selectedIndex].value.split('|');",
"Weight = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Percent_Nonsuperficial_Burn_Area_param.value.indexOf(',') >= 0){ Percent_Nonsuperficial_Burn_Area_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Percent_Nonsuperficial_Burn_Area_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"Percent_Nonsuperficial_Burn_Area = param_value;",
"dp = 0;",
"Total_Crystalloid_For_First_24_Hours =  4 * Weight * Percent_Nonsuperficial_Burn_Area;",
"",
"unit_parts = Total_Crystalloid_For_First_24_Hours_unit.options[Total_Crystalloid_For_First_24_Hours_unit.selectedIndex].value.split('|');",
"if (doCalc) Total_Crystalloid_For_First_24_Hours_param.value = fixDP((Total_Crystalloid_For_First_24_Hours - parseFloat(unit_parts[1])) / parseFloat(unit_parts[0]), dp);",
"",
"",
"",
"Rate_First_8_Hours =  Total_Crystalloid_For_First_24_Hours / 16;",
"",
"unit_parts = Rate_First_8_Hours_unit.options[Rate_First_8_Hours_unit.selectedIndex].value.split('|');",
"if (doCalc) Rate_First_8_Hours_param.value = fixDP((Rate_First_8_Hours - parseFloat(unit_parts[1])) / parseFloat(unit_parts[0]), dp);",
"",
"",
"",
"Rate_Next_16_Hours =  Total_Crystalloid_For_First_24_Hours / 32;",
"",
"unit_parts = Rate_Next_16_Hours_unit.options[Rate_Next_16_Hours_unit.selectedIndex].value.split('|');",
"if (doCalc) Rate_Next_16_Hours_param.value = fixDP((Rate_Next_16_Hours - parseFloat(unit_parts[1])) / parseFloat(unit_parts[0]), dp);",
"",
"",
"",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.BurnInjuryFluidParkland_form){",
"",
"if (Percent_Nonsuperficial_Burn_Area_param.value && Percent_Nonsuperficial_Burn_Area < 1) {",
"Percent_Nonsuperficial_Burn_Area = 0;",
"Percent_Nonsuperficial_Burn_Area_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Percent Nonsuperficial Burn Area is 1 Percent.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Percent_Nonsuperficial_Burn_Area_param.value && Percent_Nonsuperficial_Burn_Area > 100) {",
"Percent_Nonsuperficial_Burn_Area_param.value = \"\";",
"clrResults();",
"Percent_Nonsuperficial_Burn_Area = 0;",
"doCalc = false;",
"alert(\"The maximum value for Percent Nonsuperficial Burn Area is 100 Percent.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.BurnInjuryFluidParkland_form){",
"",
"Total_Crystalloid_For_First_24_Hours_param.value = '';",
"Rate_First_8_Hours_param.value = '';",
"Rate_Next_16_Hours_param.value = '';",
"",
"",
"}",
"",
"}",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
""].join("\n");
var outline_f33_34_34337=null;
var title_f33_34_34338="Patient information: Diarrhea in children (The Basics)";
var content_f33_34_34338=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?2/42/2723\">",
"         Patient information: Campylobacter infection (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?42/2/43041\">",
"         Patient information: Constipation in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?28/55/29554\">",
"         Patient information: Crohn&rsquo;s disease in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?31/62/32738\">",
"         Patient information: Dehydration (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?9/5/9299\">",
"         Patient information: Diarrhea in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/13/27858\">",
"         Patient information: Rotavirus infection (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?25/24/25986\">",
"         Patient information: Stomach ache and stomach upset (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?37/33/38418\">",
"         Patient information: Ulcerative colitis in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?9/3/9267\">",
"         Patient information: Viral gastroenteritis (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?35/29/36308\">",
"         Patient information: Acute diarrhea in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/1/27\">",
"         Patient information: Acute diarrhea in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?7/14/7395\">",
"         Patient information: Chronic diarrhea in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?28/30/29156\">",
"         Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Diarrhea in children (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/diarrhea-in-children-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H462089829\">",
"      <span class=\"h1\">",
"       How often should my child have a bowel movement?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It depends on how old he or she is:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        In the first week of life, most babies have 4 or more bowel movements each day. They are soft or liquid. It is normal for some babies to have 10 bowel movements in a day.",
"       </li>",
"       <li>",
"        In the first 3 months, some babies have 2 or more bowel movements each day. Others have just one each week.",
"       </li>",
"       <li>",
"        By age 2, most children have at least 1 bowel movement each day. They are soft but solid.",
"       </li>",
"       <li>",
"        Every child is different. Some have bowel movements after each meal. Others have bowel movements every other day.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H462089836\">",
"      <span class=\"h1\">",
"       How do I know if my child has diarrhea?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It depends on what&rsquo;s normal for your child:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        For babies, diarrhea means that bowel movements are happening more often than normal. Your baby might have twice as many bowel movements as he or she usually has. (In babies, normal bowel movements can be yellow, green or brown. They can also have things that look like seeds in them.)",
"       </li>",
"       <li>",
"        Older children with diarrhea will have three or more runny bowel movements in a day.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H462089843\">",
"      <span class=\"h1\">",
"       What are the most common causes of diarrhea in children?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The most common causes are:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Viruses",
"       </li>",
"       <li>",
"        Stomach bugs",
"       </li>",
"       <li>",
"        Side effects from antibiotics",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H462089850\">",
"      <span class=\"h1\">",
"       What should my child eat and drink when he or she has diarrhea?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your child can continue to eat a normal diet. OK foods include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Lean meats",
"       </li>",
"       <li>",
"        Rice, potatoes, and bread",
"       </li>",
"       <li>",
"        Yogurt",
"       </li>",
"       <li>",
"        Fruits and vegetables",
"       </li>",
"       <li>",
"        Milk (unless the child has problems digesting milk)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H462089857\">",
"      <span class=\"h1\">",
"       What foods and drinks should my child avoid?",
"      </span>",
"      &nbsp;&mdash;&nbsp;These foods might make diarrhea worse:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Foods that are high in fat",
"       </li>",
"       <li>",
"        Apple, pear, and cherry juice",
"       </li>",
"       <li>",
"        Drinks with lots of sugar",
"       </li>",
"       <li>",
"        Sports drinks",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H462089864\">",
"      <span class=\"h1\">",
"       What can I do to treat my child&rsquo;s diarrhea?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Make sure he or she drinks enough water and other liquids.",
"       </li>",
"       <li>",
"        Avoid diarrhea medicines. They are not usually needed for children, and they may not be safe.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H462089871\">",
"      <span class=\"h1\">",
"       When should I take my child to the doctor?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You should take your child to the doctor if he or she:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Has bloody diarrhea",
"       </li>",
"       <li>",
"        Is younger than 12 months and won&rsquo;t eat or drink anything for more than a few hours",
"       </li>",
"       <li>",
"        Has bad belly pain",
"       </li>",
"       <li>",
"        Is not acting like him or herself",
"       </li>",
"       <li>",
"        Is low in energy and does not respond to you",
"       </li>",
"       <li>",
"        Is dehydrated. Signs include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Dry mouth",
"       </li>",
"       <li>",
"        Thirst",
"       </li>",
"       <li>",
"        No urine or wet diapers for 4 to 6 hours in babies and young children, or 6 to 8 hours in older children",
"       </li>",
"       <li>",
"        No tears when crying",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H462089878\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/5/9299?source=see_link\">",
"       Patient information: Diarrhea in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/2/43041?source=see_link\">",
"       Patient information: Constipation in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/24/25986?source=see_link\">",
"       Patient information: Stomach ache and stomach upset (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/62/32738?source=see_link\">",
"       Patient information: Dehydration (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/3/9267?source=see_link\">",
"       Patient information: Viral gastroenteritis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/13/27858?source=see_link\">",
"       Patient information: Rotavirus infection (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?28/55/29554?source=see_link\">",
"       Patient information: Crohn&rsquo;s disease in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?2/42/2723?source=see_link\">",
"       Patient information: Campylobacter infection (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/33/38418?source=see_link\">",
"       Patient information: Ulcerative colitis in children (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/29/36308?source=see_link\">",
"       Patient information: Acute diarrhea in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/30/29156?source=see_link\">",
"       Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?0/1/27?source=see_link\">",
"       Patient information: Acute diarrhea in children (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?7/14/7395?source=see_link\">",
"       Patient information: Chronic diarrhea in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?33/34/34338?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15386 Version 7.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-AFBC45AB80-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34338=[""].join("\n");
var outline_f33_34_34338=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462089829\">",
"      How often should my child have a bowel movement?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462089836\">",
"      How do I know if my child has diarrhea?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462089843\">",
"      What are the most common causes of diarrhea in children?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462089850\">",
"      What should my child eat and drink when he or she has diarrhea?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462089857\">",
"      What foods and drinks should my child avoid?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462089864\">",
"      What can I do to treat my child&rsquo;s diarrhea?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462089871\">",
"      When should I take my child to the doctor?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462089878\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/29/36308?source=related_link\">",
"      Patient information: Acute diarrhea in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/1/27?source=related_link\">",
"      Patient information: Acute diarrhea in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/42/2723?source=related_link\">",
"      Patient information: Campylobacter infection (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/14/7395?source=related_link\">",
"      Patient information: Chronic diarrhea in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/2/43041?source=related_link\">",
"      Patient information: Constipation in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?28/55/29554?source=related_link\">",
"      Patient information: Crohn&rsquo;s disease in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/62/32738?source=related_link\">",
"      Patient information: Dehydration (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/5/9299?source=related_link\">",
"      Patient information: Diarrhea in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/30/29156?source=related_link\">",
"      Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/13/27858?source=related_link\">",
"      Patient information: Rotavirus infection (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/24/25986?source=related_link\">",
"      Patient information: Stomach ache and stomach upset (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/33/38418?source=related_link\">",
"      Patient information: Ulcerative colitis in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/3/9267?source=related_link\">",
"      Patient information: Viral gastroenteritis (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_34_34339="Calculator: CDC/NCHS infant length for age percentiles (<36 months)";
var content_f33_34_34339=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"CDCInfantLengthForAge_form\" name=\"CDCInfantLengthForAge_form\" onkeydown=\"clrResults();\" onkeyup=\"CDCInfantLengthForAge_fx();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: CDC/NCHS infant length for age percentiles (&lt;36 months)",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_main\">",
"     <center>",
"      <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"       <tr>",
"        <td align=\"right\" width=\"50%\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Input:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Sex",
"             </span>",
"            </td>",
"            <td align=\"left\" colspan=\"3\">",
"             <span class=\"medCalcFontOne\">",
"              <input checked=\"checked\" name=\"Sex_radio\" onclick=\"CDCInfantLengthForAge_fx();\" type=\"radio\" value=\"Female\"/>",
"              Female",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"left\">",
"             <br/>",
"            </td>",
"            <td align=\"left\" colspan=\"3\">",
"             <span class=\"medCalcFontOne\">",
"              <input name=\"Sex_radio\" onclick=\"CDCInfantLengthForAge_fx();\" type=\"radio\" value=\"Male\"/>",
"              Male",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Age",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Age_param\" onblur=\"CDCInfantLengthForAge_fx(); minMaxCheck();\" onchange=\"CDCInfantLengthForAge_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Age_unit\" onchange=\"CDCInfantLengthForAge_fx();\" style=\"width:105px;\">",
"              <option selected=\"selected\" value=\"1|0|mo\">",
"               mo",
"              </option>",
"              <option value=\"12|0|yr\">",
"               yr",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Length",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Length_param\" onblur=\"CDCInfantLengthForAge_fx(); minMaxCheck();\" onchange=\"CDCInfantLengthForAge_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Length_unit\" onchange=\"CDCInfantLengthForAge_fx();\" style=\"width:105px;\">",
"              <option selected=\"selected\" value=\"1|0|cm\">",
"               cm",
"              </option>",
"              <option value=\"2.54|0|in\">",
"               in",
"              </option>",
"              <option value=\"100|0|m\">",
"               m",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"        </td>",
"        <td align=\"left\" bgcolor=\"#eeeeee\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Results:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Z Score",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Z_Score_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Percentile",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Percentile_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"3\">",
"             &nbsp;",
"             <br/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"center\" colspan=\"3\">",
"             <span class=\"medCalcFontOneBold\">",
"              Decimal Precision:",
"             </span>",
"             <select class=\"medCalcFontSelect\" name=\"decpts\" onchange=\"CDCInfantLengthForAge_fx();\">",
"              <option>",
"               0",
"              </option>",
"              <option selected=\"selected\">",
"               1",
"              </option>",
"              <option>",
"               2",
"              </option>",
"              <option>",
"               3",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <center>",
"          <span class=\"medCalcFontOne\">",
"           <input name=\"reset\" type=\"reset\" value=\"Reset form\"/>",
"          </span>",
"         </center>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <span class=\"medCalcFontOneBold\">",
"      Notes",
"     </span>",
"     <ul class=\"medCalcFontOne\">",
"      <li>",
"       This calculator uses measured recumbent",
"       <b>",
"        Length",
"       </b>",
"       for infants and toddlers from birth through 36 months of age.",
"      </li>",
"      <li>",
"       It is not valid for standing height.",
"      </li>",
"     </ul>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Percentile conversion from Z-Score is done by table look-up in the standard Normal Table. Percentiles are provided for Z Scores between -3.09 and 3.09.  Values beyond these extremes return percentiles of 0.1 and 99.9 respectively.",
"       </span>",
"      </li>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        LMS Parameters for Girls: Infant Length for Age. National health and nutrition survey (NHANES), CDC/National Center for Health Statistics.",
"       </span>",
"      </li>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        LMS Parameters for Boys: Infant Length for Age. National health and nutrition survey (NHANES), CDC/National Center for Health Statistics.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34339=[" ",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"var currenttimeout;",
"",
"n = new Array;",
"var L = 0;",
"var M = 0;",
"var S = 0;",
"",
"n[0] = 50;",
"n[1] = 50.399;",
"n[2] = 50.798;",
"n[3] = 51.197;",
"n[4] = 51.595;",
"n[5] = 51.994;",
"n[6] = 52.392;",
"n[7] = 52.79;",
"n[8] = 53.188;",
"n[9] = 53.586;",
"n[10] = 53.983;",
"n[11] = 54.38;",
"n[12] = 54.776;",
"n[13] = 55.172;",
"n[14] = 55.567;",
"n[15] = 55.962;",
"n[16] = 56.356;",
"n[17] = 56.749;",
"n[18] = 57.142;",
"n[19] = 57.535;",
"n[20] = 57.926;",
"n[21] = 58.317;",
"n[22] = 58.706;",
"n[23] = 59.095;",
"n[24] = 59.483;",
"n[25] = 59.871;",
"n[26] = 60.257;",
"n[27] = 60.642;",
"n[28] = 61.026;",
"n[29] = 61.409;",
"n[30] = 61.791;",
"n[31] = 62.172;",
"n[32] = 62.552;",
"n[33] = 62.93;",
"n[34] = 63.307;",
"n[35] = 63.683;",
"n[36] = 64.058;",
"n[37] = 64.431;",
"n[38] = 64.803;",
"n[39] = 65.173;",
"n[40] = 65.542;",
"n[41] = 65.91;",
"n[42] = 66.276;",
"n[43] = 66.64;",
"n[44] = 67.003;",
"n[45] = 67.364;",
"n[46] = 67.724;",
"n[47] = 68.082;",
"n[48] = 68.439;",
"n[49] = 68.793;",
"n[50] = 69.146;",
"n[51] = 69.497;",
"n[52] = 69.847;",
"n[53] = 70.194;",
"n[54] = 70.54;",
"n[55] = 70.884;",
"n[56] = 71.226;",
"n[57] = 71.566;",
"n[58] = 71.904;",
"n[59] = 72.24;",
"n[60] = 72.575;",
"n[61] = 72.907;",
"n[62] = 73.237;",
"n[63] = 73.565;",
"n[64] = 73.891;",
"n[65] = 74.215;",
"n[66] = 74.537;",
"n[67] = 74.857;",
"n[68] = 75.175;",
"n[69] = 75.49;",
"n[70] = 75.804;",
"n[71] = 76.115;",
"n[72] = 76.424;",
"n[73] = 76.73;",
"n[74] = 77.035;",
"n[75] = 77.337;",
"n[76] = 77.637;",
"n[77] = 77.935;",
"n[78] = 78.23;",
"n[79] = 78.524;",
"n[80] = 78.814;",
"n[81] = 79.103;",
"n[82] = 79.389;",
"n[83] = 79.673;",
"n[84] = 79.955;",
"n[85] = 80.234;",
"n[86] = 80.511;",
"n[87] = 80.785;",
"n[88] = 81.057;",
"n[89] = 81.327;",
"n[90] = 81.594;",
"n[91] = 81.859;",
"n[92] = 82.121;",
"n[93] = 82.381;",
"n[94] = 82.639;",
"n[95] = 82.894;",
"n[96] = 83.147;",
"n[97] = 83.398;",
"n[98] = 83.646;",
"n[99] = 83.891;",
"n[100] = 84.134;",
"n[101] = 84.375;",
"n[102] = 84.614;",
"n[103] = 84.849;",
"n[104] = 85.083;",
"n[105] = 85.314;",
"n[106] = 85.543;",
"n[107] = 85.769;",
"n[108] = 85.993;",
"n[109] = 86.214;",
"n[110] = 86.433;",
"n[111] = 86.65;",
"n[112] = 86.864;",
"n[113] = 87.076;",
"n[114] = 87.286;",
"n[115] = 87.493;",
"n[116] = 87.698;",
"n[117] = 87.9;",
"n[118] = 88.1;",
"n[119] = 88.298;",
"n[120] = 88.493;",
"n[121] = 88.686;",
"n[122] = 88.877;",
"n[123] = 89.065;",
"n[124] = 89.251;",
"n[125] = 89.435;",
"n[126] = 89.617;",
"n[127] = 89.796;",
"n[128] = 89.973;",
"n[129] = 90.147;",
"n[130] = 90.32;",
"n[131] = 90.49;",
"n[132] = 90.658;",
"n[133] = 90.824;",
"n[134] = 90.988;",
"n[135] = 91.149;",
"n[136] = 91.308;",
"n[137] = 91.466;",
"n[138] = 91.621;",
"n[139] = 91.774;",
"n[140] = 91.924;",
"n[141] = 92.073;",
"n[142] = 92.22;",
"n[143] = 92.364;",
"n[144] = 92.507;",
"n[145] = 92.647;",
"n[146] = 92.785;",
"n[147] = 92.922;",
"n[148] = 93.056;",
"n[149] = 93.189;",
"n[150] = 93.319;",
"n[151] = 93.448;",
"n[152] = 93.574;",
"n[153] = 93.699;",
"n[154] = 93.822;",
"n[155] = 93.943;",
"n[156] = 94.062;",
"n[157] = 94.179;",
"n[158] = 94.295;",
"n[159] = 94.408;",
"n[160] = 94.52;",
"n[161] = 94.63;",
"n[162] = 94.738;",
"n[163] = 94.845;",
"n[164] = 94.95;",
"n[165] = 95.053;",
"n[166] = 95.154;",
"n[167] = 95.254;",
"n[168] = 95.352;",
"n[169] = 95.449;",
"n[170] = 95.543;",
"n[171] = 95.637;",
"n[172] = 95.728;",
"n[173] = 95.818;",
"n[174] = 95.907;",
"n[175] = 95.994;",
"n[176] = 96.08;",
"n[177] = 96.164;",
"n[178] = 96.246;",
"n[179] = 96.327;",
"n[180] = 96.407;",
"n[181] = 96.485;",
"n[182] = 96.562;",
"n[183] = 96.638;",
"n[184] = 96.712;",
"n[185] = 96.784;",
"n[186] = 96.856;",
"n[187] = 96.926;",
"n[188] = 96.995;",
"n[189] = 97.062;",
"n[190] = 97.128;",
"n[191] = 97.193;",
"n[192] = 97.257;",
"n[193] = 97.32;",
"n[194] = 97.381;",
"n[195] = 97.441;",
"n[196] = 97.5;",
"n[197] = 97.558;",
"n[198] = 97.615;",
"n[199] = 97.67;",
"n[200] = 97.725;",
"n[201] = 97.778;",
"n[202] = 97.831;",
"n[203] = 97.882;",
"n[204] = 97.932;",
"n[205] = 97.982;",
"n[206] = 98.03;",
"n[207] = 98.077;",
"n[208] = 98.124;",
"n[209] = 98.169;",
"n[210] = 98.214;",
"n[211] = 98.257;",
"n[212] = 98.3;",
"n[213] = 98.341;",
"n[214] = 98.382;",
"n[215] = 98.422;",
"n[216] = 98.461;",
"n[217] = 98.5;",
"n[218] = 98.537;",
"n[219] = 98.574;",
"n[220] = 98.61;",
"n[221] = 98.645;",
"n[222] = 98.679;",
"n[223] = 98.713;",
"n[224] = 98.745;",
"n[225] = 98.778;",
"n[226] = 98.809;",
"n[227] = 98.84;",
"n[228] = 98.87;",
"n[229] = 98.899;",
"n[230] = 98.928;",
"n[231] = 98.956;",
"n[232] = 98.983;",
"n[233] = 99.01;",
"n[234] = 99.036;",
"n[235] = 99.061;",
"n[236] = 99.086;",
"n[237] = 99.111;",
"n[238] = 99.134;",
"n[239] = 99.158;",
"n[240] = 99.18;",
"n[241] = 99.202;",
"n[242] = 99.224;",
"n[243] = 99.245;",
"n[244] = 99.266;",
"n[245] = 99.286;",
"n[246] = 99.305;",
"n[247] = 99.324;",
"n[248] = 99.343;",
"n[249] = 99.361;",
"n[250] = 99.379;",
"n[251] = 99.396;",
"n[252] = 99.413;",
"n[253] = 99.43;",
"n[254] = 99.446;",
"n[255] = 99.461;",
"n[256] = 99.477;",
"n[257] = 99.492;",
"n[258] = 99.506;",
"n[259] = 99.52;",
"n[260] = 99.534;",
"n[261] = 99.547;",
"n[262] = 99.56;",
"n[263] = 99.573;",
"n[264] = 99.585;",
"n[265] = 99.598;",
"n[266] = 99.609;",
"n[267] = 99.621;",
"n[268] = 99.632;",
"n[269] = 99.643;",
"n[270] = 99.653;",
"n[271] = 99.664;",
"n[272] = 99.674;",
"n[273] = 99.683;",
"n[274] = 99.693;",
"n[275] = 99.702;",
"n[276] = 99.711;",
"n[277] = 99.72;",
"n[278] = 99.728;",
"n[279] = 99.736;",
"n[280] = 99.744;",
"n[281] = 99.752;",
"n[282] = 99.76;",
"n[283] = 99.767;",
"n[284] = 99.774;",
"n[285] = 99.781;",
"n[286] = 99.788;",
"n[287] = 99.795;",
"n[288] = 99.801;",
"n[289] = 99.807;",
"n[290] = 99.813;",
"n[291] = 99.819;",
"n[292] = 99.825;",
"n[293] = 99.831;",
"n[294] = 99.836;",
"n[295] = 99.841;",
"n[296] = 99.846;",
"n[297] = 99.851;",
"n[298] = 99.856;",
"n[299] = 99.861;",
"n[300] = 99.865;",
"n[301] = 99.869;",
"n[302] = 99.874;",
"n[303] = 99.878;",
"n[304] = 99.882;",
"n[305] = 99.886;",
"n[306] = 99.889;",
"n[307] = 99.893;",
"n[308] = 99.896;",
"n[309] = 99.9;",
"",
"function ZtoPercentile(z){",
"with (document.CDCInfantLengthForAge_form){",
"az = Math.abs(z);",
"if (z < -3.09) return 0.1;",
"if (z > 3.09) return 99.9;",
"thispercentile = n[Math.round(az * 100)];",
"if (z >= 0) { return thispercentile }",
"else { return 100 - thispercentile }",
"}}",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function CDCInfantLengthForAge_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 3000);",
"",
"with(document.CDCInfantLengthForAge_form){",
"",
"",
"doCalc = true;",
"if (Sex_radio[0].checked){ Sex = 1; }",
"if (Sex_radio[1].checked){ Sex = 2; }",
"if (Age_param.value.indexOf(',') >= 0){ Age_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Age_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Age_unit.options[Age_unit.selectedIndex].value.split('|');",
"Age = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Length_param.value.indexOf(',') >= 0){ Length_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Length_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Length_unit.options[Length_unit.selectedIndex].value.split('|');",
"Length = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"dp = decpts.options[decpts.selectedIndex].text;",
"if (Sex == 1){",
"if(Age >= 0 && Age < 1){L = -0.809249882; M = 51.68358057; S = 0.046818545;};",
"if(Age >= 1 && Age < 2){L = -0.050782985; M = 55.28612813; S = 0.0434439;};",
"if(Age >= 2 && Age < 3){L = 0.476851407; M = 58.09381906; S = 0.041716103;};",
"if(Age >= 3 && Age < 4){L = 0.843299612; M = 60.45980763; S = 0.040705173;};",
"if(Age >= 4 && Age < 5){L = 1.097562257; M = 62.53669656; S = 0.040079765;};",
"if(Age >= 5 && Age < 6){L = 1.272509641; M = 64.40632762; S = 0.039686845;};",
"if(Age >= 6 && Age < 7){L = 1.390428859; M = 66.11841553; S = 0.039444555;};",
"if(Age >= 7 && Age < 8){L = 1.466733925; M = 67.70574419; S = 0.039304738;};",
"if(Age >= 8 && Age < 9){L = 1.512301976; M = 69.19123614; S = 0.03923711;};",
"if(Age >= 9 && Age < 10){L = 1.534950767; M = 70.59163924; S = 0.039221665;};",
"if(Age >= 10 && Age < 11){L = 1.540390875; M = 71.91961673; S = 0.039244672;};",
"if(Age >= 11 && Age < 12){L = 1.532852892; M = 73.1850104; S = 0.03929642;};",
"if(Age >= 12 && Age < 13){L = 1.51550947; M = 74.39564379; S = 0.039369875;};",
"if(Age >= 13 && Age < 14){L = 1.490765028; M = 75.5578544; S = 0.039459832;};",
"if(Age >= 14 && Age < 15){L = 1.460458255; M = 76.67685871; S = 0.039562382;};",
"if(Age >= 15 && Age < 16){L = 1.426006009; M = 77.75700986; S = 0.039674542;};",
"if(Age >= 16 && Age < 17){L = 1.388507095; M = 78.80198406; S = 0.03979401;};",
"if(Age >= 17 && Age < 18){L = 1.348818127; M = 79.81491852; S = 0.039918994;};",
"if(Age >= 18 && Age < 19){L = 1.307609654; M = 80.79851532; S = 0.040048084;};",
"if(Age >= 19 && Age < 20){L = 1.265408149; M = 81.75512092; S = 0.040180162;};",
"if(Age >= 20 && Age < 21){L = 1.222627732; M = 82.6867881; S = 0.04031434;};",
"if(Age >= 21 && Age < 22){L = 1.179594365; M = 83.59532461; S = 0.040449904;};",
"if(Age >= 22 && Age < 23){L = 1.136564448; M = 84.48233206; S = 0.040586283;};",
"if(Age >= 23 && Age < 24){L = 1.093731947; M = 85.34923624; S = 0.040723015;};",
"if(Age >= 24 && Age < 25){L = 1.051272912; M = 86.1973169; S = 0.040859727;};",
"if(Age >= 25 && Age < 26){L = 1.041951175; M = 87.09026318; S = 0.041142161;};",
"if(Age >= 26 && Age < 27){L = 1.012592236; M = 87.95714182; S = 0.041349399;};",
"if(Age >= 27 && Age < 28){L = 0.970541909; M = 88.7960184; S = 0.041500428;};",
"if(Age >= 28 && Age < 29){L = 0.921129988; M = 89.6055115; S = 0.041610508;};",
"if(Age >= 29 && Age < 30){L = 0.868221392; M = 90.38476689; S = 0.041691761;};",
"if(Age >= 30 && Age < 31){L = 0.81454413; M = 91.13341722; S = 0.04175368;};",
"if(Age >= 31 && Age < 32){L = 0.761957977; M = 91.8515436; S = 0.041803562;};",
"if(Age >= 32 && Age < 33){L = 0.711660228; M = 92.5396352; S = 0.041846882;};",
"if(Age >= 33 && Age < 34){L = 0.664323379; M = 93.19854429; S = 0.041887626;};",
"if(Age >= 34 && Age < 35){L = 0.620285102; M = 93.82945392; S = 0.041928568;};",
"if(Age >= 35 && Age < 36){L = 0.57955631; M = 94.43382278; S = 0.041971514;};",
"}",
"if (Sex == 2){",
"if(Age >= 0 && Age < 1){L = 0.511237696; M = 52.6959753; S = 0.048692684;};",
"if(Age >= 1 && Age < 2){L = -0.45224446; M = 56.62842855; S = 0.04411683;};",
"if(Age >= 2 && Age < 3){L = -0.990594599; M = 59.60895343; S = 0.041795583;};",
"if(Age >= 3 && Age < 4){L = -1.285837689; M = 62.07700027; S = 0.040454126;};",
"if(Age >= 4 && Age < 5){L = -1.43031238; M = 64.2168641; S = 0.039633879;};",
"if(Age >= 5 && Age < 6){L = -1.47657547; M = 66.1253149; S = 0.039123813;};",
"if(Age >= 6 && Age < 7){L = -1.456837849; M = 67.8601799; S = 0.038811994;};",
"if(Age >= 7 && Age < 8){L = -1.391898768; M = 69.45908458; S = 0.038633209;};",
"if(Age >= 8 && Age < 9){L = -1.29571459; M = 70.94803912; S = 0.038546833;};",
"if(Age >= 9 && Age < 10){L = -1.177919048; M = 72.34586111; S = 0.038526262;};",
"if(Age >= 10 && Age < 11){L = -1.045326049; M = 73.6666541; S = 0.038553387;};",
"if(Age >= 11 && Age < 12){L = -0.902800887; M = 74.92129717; S = 0.038615501;};",
"if(Age >= 12 && Age < 13){L = -0.753908107; M = 76.11837536; S = 0.038703461;};",
"if(Age >= 13 && Age < 14){L = -0.601263523; M = 77.26479911; S = 0.038810557;};",
"if(Age >= 14 && Age < 15){L = -0.446805039; M = 78.36622309; S = 0.038931784;};",
"if(Age >= 15 && Age < 16){L = -0.291974772; M = 79.4273405; S = 0.039063356;};",
"if(Age >= 16 && Age < 17){L = -0.13784767; M = 80.45209492; S = 0.039202382;};",
"if(Age >= 17 && Age < 18){L = 0.014776155; M = 81.44383603; S = 0.039346629;};",
"if(Age >= 18 && Age < 19){L = 0.165304169; M = 82.40543643; S = 0.039494365;};",
"if(Age >= 19 && Age < 20){L = 0.313301809; M = 83.33938063; S = 0.039644238;};",
"if(Age >= 20 && Age < 21){L = 0.458455471; M = 84.24783394; S = 0.039795189;};",
"if(Age >= 21 && Age < 22){L = 0.600544631; M = 85.13269658; S = 0.039946388;};",
"if(Age >= 22 && Age < 23){L = 0.739438953; M = 85.9956488; S = 0.040097181;};",
"if(Age >= 23 && Age < 24){L = 0.875000447; M = 86.8381751; S = 0.04024706;};",
"if(Age >= 24 && Age < 25){L = 1.00720807; M = 87.66160934; S = 0.040395626;};",
"if(Age >= 25 && Age < 26){L = 0.837251351; M = 88.45247282; S = 0.040577525;};",
"if(Age >= 26 && Age < 27){L = 0.681492975; M = 89.22326434; S = 0.040723122;};",
"if(Age >= 27 && Age < 28){L = 0.538779654; M = 89.97549228; S = 0.040833194;};",
"if(Age >= 28 && Age < 29){L = 0.407697153; M = 90.71040853; S = 0.040909059;};",
"if(Age >= 29 && Age < 30){L = 0.286762453; M = 91.42907762; S = 0.040952433;};",
"if(Age >= 30 && Age < 31){L = 0.174489485; M = 92.13242379; S = 0.04096533;};",
"if(Age >= 31 && Age < 32){L = 0.069444521; M = 92.82127167; S = 0.040949976;};",
"if(Age >= 32 && Age < 33){L = -0.029720564; M = 93.49637946; S = 0.040908737;};",
"if(Age >= 33 && Age < 34){L = -0.124251789; M = 94.15846546; S = 0.040844062;};",
"if(Age >= 34 && Age < 35){L = -0.215288396; M = 94.80822923; S = 0.040758431;};",
"if(Age >= 35 && Age < 36){L = -0.30385434; M = 95.44636981; S = 0.040654312;};",
"}",
"Z_Score =  (power((Length / M), L) - 1) / (L * S);",
"",
"if (doCalc) Z_Score_param.value = fixDP(Z_Score, dp);",
"",
"",
"",
"Percentile =  ZtoPercentile(Z_Score);",
"",
"if (doCalc) Percentile_param.value = fixDP(Percentile, dp);",
"",
"",
"",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.CDCInfantLengthForAge_form){",
"",
"if (Age_param.value && Age < 0) {",
"Age = 0;",
"Age_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Age is 0 mo.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Age_param.value && Age > 35.99) {",
"Age_param.value = \"\";",
"clrResults();",
"Age = 0;",
"doCalc = false;",
"alert(\"The maximum value for Age is 35.99 mo.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Length_param.value && Length < 10) {",
"Length = 0;",
"Length_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Length is 10 cm.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Length_param.value && Length > 300) {",
"Length_param.value = \"\";",
"clrResults();",
"Length = 0;",
"doCalc = false;",
"alert(\"The maximum value for Length is 300 cm.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.CDCInfantLengthForAge_form){",
"",
"Z_Score_param.value = '';",
"Percentile_param.value = '';",
"",
"",
"}",
"",
"}",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
""].join("\n");
var outline_f33_34_34339=null;
var title_f33_34_34340="Mesna: Patient drug information";
var content_f33_34_34340=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Mesna: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/0/41989?source=see_link\">",
"     see \"Mesna: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?43/22/44388?source=see_link\">",
"     see \"Mesna: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F193506\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Mesnex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F193507\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Mesna for injection;",
"     </li>",
"     <li>",
"      Uromitexan",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015831\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691346",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower the bad effects of some cancer drugs on the bladder.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015830\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702477",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to mesna or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015835\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697158",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an autoimmune disease such as rheumatoid arthritis or lupus, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015836\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015838\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you throw up within 2 hours of taking the oral drug. The dose may need to be repeated.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698609",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blood in the urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015833\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696081",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may be taken by mouth.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696079",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may be mixed with water, milk, juice, or a carbonated drink.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696067",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may be given as a shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696035",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is given with your cancer drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may be given with your cancer drug and for 2 or more extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696083",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use this drug as ordered by your doctor. Read and follow the dosing on the label closely.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10015834\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015839\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015840\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11252 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-AF7A4312D5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34340=[""].join("\n");
var outline_f33_34_34340=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193506\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193507\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015831\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015830\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015835\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015836\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015838\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015833\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015834\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015839\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015840\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?41/0/41989?source=related_link\">",
"      Mesna: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?43/22/44388?source=related_link\">",
"      Mesna: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_34_34341="Isocarboxazid: Patient drug information";
var content_f33_34_34341=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Isocarboxazid: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/15/8439?source=see_link\">",
"     see \"Isocarboxazid: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F184651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Marplan&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10020261\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700557",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Children and teens who take this drug may be at a greater risk of having thoughts or actions of suicide. Adults may also be at risk. The risk may be greater in people who have had these thoughts or actions in the past. Watch people who take this drug closely. Call the doctor right away if signs like low mood (depression), nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10020263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691809",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat low mood (depression). It is most often given after other drugs have failed to help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10020262\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to isocarboxazid or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703652",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Kidney disease, liver disease, pheochromocytoma, stroke, very high blood pressure, or very weak heart.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701242",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking any of these drugs: Citalopram, fluvoxamine, paroxetine, or sertraline. Do not use within 2 weeks of other antidepressants.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701004",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Stop fluoxetine for at least 5 weeks before starting this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701346",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you cannot follow the diet needed when taking this drug. See How Is This Drug Best Taken? for more details.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10020267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug with other drugs for low mood (depression), diet pills, stimulants like amphetamines, reserpine, or pain drugs. There needs to be 2 weeks between stopping one drug and starting the other.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696931",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use OTC drugs that have dextromethorphan or pseudoephedrine. They may cause very high blood pressure when used with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696620",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks. Alcohol may cause very high blood pressure even 2 weeks after the drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696635",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid use of caffeine (for example, tea, coffee, cola) and chocolate. Use with this drug may cause high blood pressure, nervousness, shakiness, a fast heartbeat, and anxiety.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10020268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698132",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood pressure may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10020270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698706",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are planning to harm yourself or the want to harm yourself gets worse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure, a fast heartbeat, or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698632",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Confusion; very nervous; anger with sweating, shivering, stiffness, or shaking.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10020265\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694864",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow a diet plan. Some foods and drinks taken with this drug may cause very risky effects such as sudden high blood pressure. To avoid these problems, get a list of foods to avoid.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694534",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid eating foods like aged cheeses and meats, soy sauce, soy beans, Miso soup, Italian green beans (fava beans), snowpea or broad bean pods, sauerkraut, kimchee, yeast extracts (Marmite), red or white wine, and beer including alcohol-free beer. Very bad side effects may happen. Ask your doctor for a list of foods to avoid.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695129",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If this drug is stopped, follow diet for at least 2 more weeks.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10020266\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10020271\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10020272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10773 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-69ABC6F150-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34341=[""].join("\n");
var outline_f33_34_34341=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F184651\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020261\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020263\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020262\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020267\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020268\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020270\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020265\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020266\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020271\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020272\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?8/15/8439?source=related_link\">",
"      Isocarboxazid: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_34_34342="Nickel hypersensitivity and coronary artery stents";
var content_f33_34_34342=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Nickel hypersensitivity and coronary artery stents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?33/34/34342/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?33/34/34342/contributors\">",
"     Sarita U Patil, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?33/34/34342/contributors\">",
"     Aidan Long, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?33/34/34342/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?33/34/34342/contributors\">",
"     Bruce S Bochner, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?33/34/34342/contributors\">",
"     Donald Cutlip, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?33/34/34342/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?33/34/34342/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?33/34/34342/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 29, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Within the past decade, there has been growing concern about possible allergic (hypersensitivity) reactions to foreign materials implanted in the body. A question that has frequently generated consults to allergy specialists is whether hypersensitivity reactions to materials in intracoronary artery stents could be associated with stent restenosis.",
"   </p>",
"   <p>",
"    Many coronary stents are made from stainless steel, which is steel with added nickel and chromium, and nickel is one of the most common causes of allergic contact dermatitis. Thus, a possible association between nickel hypersensitivity and stent restenosis has been questioned.",
"   </p>",
"   <p>",
"    The evidence supporting and refuting an association between nickel hypersensitivity and intracoronary artery stent restenosis will be reviewed here. Restenosis of intracoronary stents is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/46/24298?source=see_link\">",
"     \"Intracoronary stent restenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;A brief review of nickel hypersensitivity and the composition of intracoronary stents is helpful in understanding the studies presented in this topic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Metal hypersensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common form of metal hypersensitivity is allergic contact dermatitis (ACD) caused by nickel. Cobalt, chromium, molybdenum, and gold are less often implicated in ACD [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/1\">",
"     1",
"    </a>",
"    ]. Estimates of the prevalence of nickel sensitivity in the general population range from 4 to 19 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Nickel is found in many commercial products, including zippers, buttons, jewelry, watches, eye glass frames, and mobile phones, and many of these items have been linked to contact dermatitis reactions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Allergic contact dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;ACD is a form of cutaneous hypersensitivity that may develop in susceptible individuals when the skin has direct and repeated contact with an allergen. The development of ACD involves two phases: an initial induction phase, during which sensitization to the allergen occurs, followed by an elicitation phase, when reexposure to the allergen results in cutaneous inflammation at the site of contact. It presents clinically as a red, pruritic rash, often with areas of vesiculation (",
"    <a class=\"graphic graphic_picture graphicRef70989 \" href=\"UTD.htm?32/27/33203\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    ACD is a usually a subacute or chronic disorder mediated by allergen-specific T cells in the skin. It is a type IV (or delayed) hypersensitivity that does NOT involve sudden or immediate allergic reactions, systemic features, or escalate to anaphylaxis, which are characteristics of type I hypersensitivity reactions.",
"   </p>",
"   <p>",
"    ACD is diagnosable by allergen patch testing, which involves placement of the allergen on the skin surface for 48 hours under occlusion, followed by removal and examination of the skin for inflammatory changes at 48 hours and again usually 24 hours after the initial examination. The diagnosis and treatment of ACD are reviewed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26104?source=see_link\">",
"     \"Contact dermatitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for the development of nickel hypersensitivity include environmental exposure to nickel, smoking, and body piercing, as well as mutations in the filaggrin gene [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/1-5\">",
"     1-5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Materials in coronary stents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coronary stents are most commonly made from stainless steel, which is steel with added nickel and chromium. Less frequently, stents are made of a non-stainless steel cobalt and chromium alloy that contains a very low amount of nickel.",
"   </p>",
"   <p>",
"    The stents most commonly used in the United States (US) are composed of 316L stainless steel, which contains nickel (about 12 percent), chromium (as chromate, 17 percent), and molybdenum (about 2 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Stents made from these metals are available as either bare metal devices or drug eluting devices coated with polymers containing immunosuppressive medications, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/4/6218?source=see_link\">",
"     everolimus",
"    </a>",
"    , zotarolimus, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    . In the US, the majority of stenting procedures use drug eluting stents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24889?source=see_link\">",
"     \"General principles of the use of intracoronary stents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     POSSIBLE MANIFESTATIONS OF METAL HYPERSENSITIVITY IN IMPLANT RECIPIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In theory, sensitization to nickel and other metals as a result of coronary stent placement is possible, although it has not been convincingly demonstrated.",
"   </p>",
"   <p>",
"    No study has performed patch testing to stent materials before and after coronary stent placement. One study did evaluate the incidence of gold and nickel hypersensitivity in patients who had previously received gold plated stainless steel stents or bare stainless steel stents [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/7\">",
"     7",
"    </a>",
"    ]. Patients with gold plated coronary stents had a statistically higher rate of positive patch testing to gold, compared to an age- and sex-matched control group with dermatitis but without stent implants (54 of 146, 37 percent versus 85 of 447, 19 percent), implying that gold metal sensitization could occur as a result of stent implantation. However, a similar association was not found for nickel sensitization in those patients with bare metal stainless stents.",
"   </p>",
"   <p>",
"    Interventional closure devices for the treatment of atrial septal defect and patent foramen ovale (eg, Amplatzer device) have been developed with nitinol, an alloy containing 55 percent nickel. A study of 67 patients demonstrated significant increases in serum nickel levels in the days after implantation, although the highest levels were still within the normal range [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/8\">",
"     8",
"    </a>",
"    ]. Elevations in serum nickel peaked at one month and fell gradually thereafter. Sensitization to nickel was not assessed, but the patients in this study reported no symptoms to suggest problems with the devices.",
"   </p>",
"   <p>",
"    There have been case reports of associated pericarditis, palpitations, chest pain, migraine headaches, and \"device hypersensitivity syndrome\" after implantation of Amplatzer devices [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. One study drew a link between such symptoms and nickel patch test positivity [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with metal-containing implants, metal hypersensitivity has been implicated in at least two types of problems: cutaneous reactions and implant",
"    <span class=\"nowrap\">",
"     dysfunction/failure.",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cutaneous inflammation: The evidence for cutaneous hypersensitivity reactions suggestive of metal ACD are mostly case reports in patients with implanted orthopedic devices or oral implants [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/14-17\">",
"       14-17",
"      </a>",
"      ]. Reported manifestations were most commonly eczematous dermatitis, or in the case of oral devices, irritation of mucosal surfaces adjacent to the device.",
"      <br/>",
"      <br/>",
"      In the orthopedic case reports, development of an eczematous dermatitis of the skin overlying the implant site has been described in patients with nickel hypersensitivity [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/18,19\">",
"       18,19",
"      </a>",
"      ], although one study of four patients concluded that this presentation represented atypical cellulitis because it cleared with prolonged antibiotic therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/20\">",
"       20",
"      </a>",
"      ]. Diffuse dermatitis has also been described after implantation of various types of nickel containing orthopedic implants [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/21,22\">",
"       21,22",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      For stainless steel coronary stents (either bare-metal or drug eluting stents) specifically, we are not aware of any case reports of",
"      <strong>",
"       localized",
"      </strong>",
"      cutaneous adverse reactions suggestive of nickel allergic contact dermatitis after placement. A very small number of cases of",
"      <strong>",
"       generalized",
"      </strong>",
"      cutaneous symptoms (diffuse pruritus or nonurticarial rash) have been reported although a causal relationship to stent placement was not demonstrated [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/6,23\">",
"       6,23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Implant dysfunction and failure &mdash; There are case reports and small studies suggesting an association between failure of hip replacement and metal contact dermatitis, as well as new tissue formation around the metal prostheses [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/24-28\">",
"       24-28",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      A 2009 case-control study examined 356 patients who underwent hip arthroplasty and subsequent revision [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/29\">",
"       29",
"      </a>",
"      ]. There was no significant difference in the frequency of revision in patients with positive patch testing to metals. Other studies of implant failure in patients with nickel hypersensitivity reported mixed results [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/26,30-32\">",
"       26,30-32",
"      </a>",
"      ]. However, case control studies and prospective trials on larger populations failed to confirm a correlation between implant failure and sensitization to metals [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/29,30,33\">",
"       29,30,33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     STUDIES OF STENT RESTENOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The issue that has raised persistent questions with regard to metal hypersensitivity and intracoronary stents is implant failure in the form of restenosis. Most studies have examined the rates of nickel sensitivity, as determined by patch testing to nickel, in patients who have previously received nickel-containing stents. However, false positives are possible with patch testing, since some patients with a positive patch test to nickel do not have clinical contact dermatitis. Likewise, many patients with a clinical history suggestive of metal associated dermatitis do not have positive patch tests to metals [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/6\">",
"     6",
"    </a>",
"    ]. The sensitivity and specificity of patch testing in patients with ACD is approximately 70 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Initial restenosis of bare metal stents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Concern of an increased rate of stent restenosis in nickel-allergic patients with bare metal stainless steel stents first arose from retrospective studies [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/6,35-37\">",
"     6,35-37",
"    </a>",
"    ]. As an example, one study described 131 consecutive patients who underwent repeat coronary angiography because of clinical concern about stent restenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/6\">",
"     6",
"    </a>",
"    ]. Patch testing to metals (including nickel, molybdenum, and chromate) identified 10 patients (8 percent) with sensitivity to nickel or molybdenum, a prevalence not different from that expected in the general population. However, all 10 of these patients had restenosis, whereas only 79 of the 121 patients (65 percent) with negative patch testing had restenosis, a statistically significant difference.",
"   </p>",
"   <p>",
"    Prospective studies, however, have",
"    <strong>",
"     not",
"    </strong>",
"    confirmed an association between stent restenosis and nickel sensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A large prospective study described 109 consecutive patients who underwent both coronary angiography and patch testing to nickel, six months after bare metal stent placement [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/38\">",
"       38",
"      </a>",
"      ]. Stenosis was identified in 20 patients (18 percent), but was not associated with a higher incidence of positive patch tests to nickel.",
"     </li>",
"     <li>",
"      A prospective study of 43 patients with bare metal stents also did not find an increased risk of restenosis in patients with positive patch testing to nickel [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/39\">",
"       39",
"      </a>",
"      ]. Coronary angiography six months after stent placement found that 37 percent of patients had &gt; 50 percent restenosis. All patients underwent patch testing to nickel. Three patients were sensitive to nickel, of whom one (33 percent) had stent restenosis. Thus, the rate of restenosis was in nickel-allergic patients was similar to the rate in the group as a whole.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In summary, case reports and retrospective series suggested an association between nickel sensitivity (as demonstrated by patch testing) and stent restenosis, but the higher quality evidence provided by prospective studies has not confirmed this relationship.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Drug eluting stents",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few studies comparing bare metal stents and drug eluting stents (DES) with respect to nickel sensitivity and rates of restenosis. It is theoretically possible that the immunosuppressive drugs eluted by these stents suppress local inflammatory responses, including hypersensitivity responses.",
"   </p>",
"   <p>",
"    One study examined the relationship between nickel sensitivity and restenosis after placement of a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    eluting stent [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/40\">",
"     40",
"    </a>",
"    ]. In this study, 88 patients underwent metal patch testing and repeat coronary angiography at eight months after placement of the stent. Fourteen patients (16 percent) were patch test positive to metals, including nickel, chromate, and manganese. The rate of restenosis in patch test positive patients did not significantly differ from restenosis in patch test negative patients (6.3 percent versus 6.5 percent). In addition, there was also no difference in the degree of luminal loss due to stenosis in patch test positive or negative patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Recurrent stent restenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small number of studies have noted a possible association between nickel sensitivity and",
"    <strong>",
"     recurrent",
"    </strong>",
"    stent restenosis. Taken together, these studies indicate that there may be a subset of patients who experience",
"    <strong>",
"     recurrent",
"    </strong>",
"    restenosis, in whom the pathogenesis of the restenosis is related to nickel hypersensitivity in some manner.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the prospective study of 109 patients described previously, a group of 65 patients, who had undergone angioplasty in response to a first episode of stent restenosis, were evaluated six months later with repeat angiography [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/38\">",
"       38",
"      </a>",
"      ]. In this subgroup, 21 percent of patients were sensitive to nickel. Those subjects with a second in-stent restenosis were found to have a significantly higher rate of nickel sensitivity, compared to those who did not (39 percent and 12 percent, respectively). Thus, this study did not find an association between nickel sensitivity and",
"      <strong>",
"       initial",
"      </strong>",
"      stent restenosis, as discussed previously, although it did suggest a relationship between nickel hypersensitivity and",
"      <strong>",
"       recurrent",
"      </strong>",
"      restenosis.",
"     </li>",
"     <li>",
"      A subsequent study described 128 patients who underwent evaluation for possible second stent restenosis, after having had angioplasty for prior stent restenosis [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/41\">",
"       41",
"      </a>",
"      ]. Nineteen percent of the group was sensitized to nickel. Of the 60 patients with confirmed second in-stent restenosis, 18 (30 percent) were sensitized to nickel compared to 6 of the 68 (9 percent) of the group without further in-stent stenosis, a statistically significant difference.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    One possible explanation for the above findings is that performance of angioplasty on a stenotic stent site disrupts the vessel intima and increases the risk of developing nickel sensitivity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     IN-STENT THROMBOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In-stent thrombosis and systemic hypersensitivity reactions have been reported in patients with drug eluting coronary stents. The reported symptoms included symptoms of rash, dyspnea, itching, hives, and fevers. The Research on Adverse Drug Events and Reports (RADAR) project was a large study of hypersensitivity reactions associated with drug eluting stents, collected from the US FDA database [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34342/abstract/23\">",
"     23",
"    </a>",
"    ]. It sought to determine whether the likely cause of these reactions was a component of the drug eluting stents or a concomitantly prescribed medication. Of the 5783 reports of hypersensitivity associated with drug eluting stents, 17 cases (0.3 percent) were attributed to the stents rather than to medications. Of those 17 cases, there were 4 autopsy reports of in-stent eosinophilic inflammation, thrombosis, and lack of intimal healing. The conclusion was that hypersensitivity to some component of drug eluting stents could be a rare cause of systemic hypersensitivity reactions, possibly associated with in-stent thrombosis and death. Information about nickel hypersensitivity was not collected in this study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intracoronary stents are usually made of stainless steel, which contains nickel, chromium, and molybdenum. Nickel is one of the most common causes of allergic contact dermatitis (ACD). There are also low-nickel versions of both bare metal and drug eluting stents. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Background'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Based upon early case reports and retrospective studies, nickel sensitivity was implicated in",
"      <strong>",
"       initial",
"      </strong>",
"      restenosis of",
"      <strong>",
"       bare metal",
"      </strong>",
"      stents. However, prospective studies have not confirmed an association. There are no data to suggest that nickel sensitivity increases the risk of restenosis of",
"      <strong>",
"       drug eluting",
"      </strong>",
"      stents either. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Studies of stent restenosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that possible hypersensitivity to nickel should NOT be a factor in deciding which coronary stent to choose for a patient (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      We suggest that possible hypersensitivity to nickel should NOT be a factor in managing patients with stent restenosis (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The situation in patients with",
"      <strong>",
"       recurrent",
"      </strong>",
"      restenosis is less clear, since two studies found higher rates of repeated restenosis in nickel sensitive patients whose stents had been previously instrumented. Thus, the possibility that nickel sensitivity may contribute to repeat episodes of stent restenosis has not been excluded. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Recurrent stent restenosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/1\">",
"      Thyssen JP, Menn&eacute; T. Metal allergy--a review on exposures, penetration, genetics, prevalence, and clinical implications. Chem Res Toxicol 2010; 23:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/2\">",
"      Thyssen JP, Linneberg A, Menn&eacute; T, Johansen JD. The epidemiology of contact allergy in the general population--prevalence and main findings. Contact Dermatitis 2007; 57:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/3\">",
"      Jensen CS, Lisby S, Baadsgaard O, et al. Decrease in nickel sensitization in a Danish schoolgirl population with ears pierced after implementation of a nickel-exposure regulation. Br J Dermatol 2002; 146:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/4\">",
"      Thyssen JP, Johansen JD, Menn&eacute; T, et al. Nickel allergy in Danish women before and after nickel regulation. N Engl J Med 2009; 360:2259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/5\">",
"      Novak N, Baurecht H, Sch&auml;fer T, et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 2008; 128:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/6\">",
"      K&ouml;ster R, Vieluf D, Kiehn M, et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 2000; 356:1895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/7\">",
"      Ekqvist S, Svedman C, M&ouml;ller H, et al. High frequency of contact allergy to gold in patients with endovascular coronary stents. Br J Dermatol 2007; 157:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/8\">",
"      Ries MW, Kampmann C, Rupprecht HJ, et al. Nickel release after implantation of the Amplatzer occluder. Am Heart J 2003; 145:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/9\">",
"      Fukahara K, Minami K, Reiss N, et al. Systemic allergic reaction to the percutaneous patent foramen ovale occluder. J Thorac Cardiovasc Surg 2003; 125:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/10\">",
"      Lai DW, Saver JL, Araujo JA, et al. Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: a case report. Catheter Cardiovasc Interv 2005; 66:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/11\">",
"      Wertman B, Azarbal B, Riedl M, Tobis J. Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure. J Am Coll Cardiol 2006; 47:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/12\">",
"      Rabkin DG, Whitehead KJ, Michaels AD, et al. Unusual presentation of nickel allergy requiring explantation of an Amplatzer atrial septal occluder device. Clin Cardiol 2009; 32:E55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/13\">",
"      Slavin L, Tobis JM, Rangarajan K, et al. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol 2007; 99:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/14\">",
"      M&ouml;ller H. Dental gold alloys and contact allergy. Contact Dermatitis 2002; 47:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/15\">",
"      Ehrnrooth M, Kerosuo H. Face and neck dermatitis from a stainless steel orthodontic appliance. Angle Orthod 2009; 79:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/16\">",
"      Kolokitha OE, Chatzistavrou E. A severe reaction to ni-containing orthodontic appliances. Angle Orthod 2009; 79:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/17\">",
"      Noble J, Ahing SI, Karaiskos NE, Wiltshire WA. Nickel allergy and orthodontics, a review and report of two cases. Br Dent J 2008; 204:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/18\">",
"      Banerjee P, White IR. Allergic contact dermatitis at the application site of an electrosurgical earthing plate occurring in a windscreen repairer. Contact Dermatitis 2001; 44:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/19\">",
"      Barranco VP, Soloman H. Eczematous dermatitis from nickel. JAMA 1972; 220:1244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/20\">",
"      Durupt F, Dalle S, Ronger S, Thomas L. Does erysipelas-like rash after hip replacement exist? Dermatology 2006; 212:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/21\">",
"      Grimalt F, Romaguera C. Acute nickel dermatitis from a metal implant. Contact Dermatitis 1980; 6:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/22\">",
"      Smith E, Mehta AJ, Statham BN. Metal sensitivity to Elektra prostheses - two cases from a metal on metal implant for hand joint replacement. Contact Dermatitis 2009; 60:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/23\">",
"      Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006; 47:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/24\">",
"      Krecisz B, Kie-Swierczyska M, Bakowicz-Mitura K. Allergy to metals as a cause of orthopedic implant failure. Int J Occup Med Environ Health 2006; 19:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/25\">",
"      Mahendra G, Pandit H, Kliskey K, et al. Necrotic and inflammatory changes in metal-on-metal resurfacing hip arthroplasties. Acta Orthop 2009; 80:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/26\">",
"      Thomas P, Braathen LR, D&ouml;rig M, et al. Increased metal allergy in patients with failed metal-on-metal hip arthroplasty and peri-implant T-lymphocytic inflammation. Allergy 2009; 64:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/27\">",
"      Pigatto PD, Guzzi G, Brambilla L, Sforza C. Titanium allergy associated with dental implant failure. Clin Oral Implants Res 2009; 20:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/28\">",
"      Sicilia A, Cuesta S, Coma G, et al. Titanium allergy in dental implant patients: a clinical study on 1500 consecutive patients. Clin Oral Implants Res 2008; 19:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/29\">",
"      Thyssen JP, Jakobsen SS, Engkilde K, et al. The association between metal allergy, total hip arthroplasty, and revision. Acta Orthop 2009; 80:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/30\">",
"      Duchna HW, Nowack U, Merget R, et al. [Prospective study of the significance of contact sensitization caused by metal implants]. Zentralbl Chir 1998; 123:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/31\">",
"      Hallab N, Merritt K, Jacobs JJ. Metal sensitivity in patients with orthopaedic implants. J Bone Joint Surg Am 2001; 83-A:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/32\">",
"      Schuh A, Zeiler G, Werber S. [Results and experiences of conversion of hip arthrodesis ]. Orthopade 2005; 34:218, 220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/33\">",
"      Schuh A, Lill C, H&ouml;nle W, Effenberger H. [Prevalence of allergic reactions to implant materials in total hip and knee arthroplasty]. Zentralbl Chir 2008; 133:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/34\">",
"      Nethercott JR. Practical problems in the use of patch testing in the evaluation of patients with contact dermatitis. Curr Probl Dermatol 1990; 2:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/35\">",
"      Svedman C, Ekqvist S, M&ouml;ller H, et al. A correlation found between contact allergy to stent material and restenosis of the coronary arteries. Contact Dermatitis 2009; 60:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/36\">",
"      Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/37\">",
"      Hillen U, Haude M, Erbel R, Goos M. Evaluation of metal allergies in patients with coronary stents. Contact Dermatitis 2002; 47:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/38\">",
"      Iijima R, Ikari Y, Amiya E, et al. The impact of metallic allergy on stent implantation: metal allergy and recurrence of in-stent restenosis. Int J Cardiol 2005; 104:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/39\">",
"      Norgaz T, Hobikoglu G, Serdar ZA, et al. Is there a link between nickel allergy and coronary stent restenosis? Tohoku J Exp Med 2005; 206:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/40\">",
"      Nakazawa G, Tanabe K, Aoki J, et al. Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy. Circ J 2008; 72:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34342/abstract/41\">",
"      Saito T, Hokimoto S, Oshima S, et al. Metal allergic reaction in chronic refractory in-stent restenosis. Cardiovasc Revasc Med 2009; 10:17.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5556 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-A00CD60D9C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34342=[""].join("\n");
var outline_f33_34_34342=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Metal hypersensitivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Allergic contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Materials in coronary stents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      POSSIBLE MANIFESTATIONS OF METAL HYPERSENSITIVITY IN IMPLANT RECIPIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      STUDIES OF STENT RESTENOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Initial restenosis of bare metal stents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Drug eluting stents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Recurrent stent restenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      IN-STENT THROMBOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/5556\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/5556|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/27/33203\" title=\"picture 1\">",
"      Nickel allergy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26104?source=related_link\">",
"      Contact dermatitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24889?source=related_link\">",
"      General principles of the use of intracoronary stents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/46/24298?source=related_link\">",
"      Intracoronary stent restenosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_34_34343="Paper wasp nest";
var content_f33_34_34343=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F77793&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F77793&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Paper wasp nest",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 424px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Nancy Bresich, PhD and Albert Greene, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34343=[""].join("\n");
var outline_f33_34_34343=null;
var title_f33_34_34344="Human immunodeficiency virus and dialysis";
var content_f33_34_34344=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Human immunodeficiency virus and dialysis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?33/34/34344/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?33/34/34344/contributors\">",
"     Paul E Klotman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?33/34/34344/contributors\">",
"     Christina M Wyatt, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?33/34/34344/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?33/34/34344/contributors\">",
"     Steve J Schwab, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?33/34/34344/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?33/34/34344/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?33/34/34344/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?33/34/34344/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 9, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Kidney disease is an important complication of human immunodeficiency virus (HIV) infection, particularly in African-Americans [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/1\">",
"     1",
"    </a>",
"    ]. A collapsing form of focal segmental glomerulosclerosis (FSGS) with associated tubular microcysts and interstitial inflammation is the classic form of HIV-associated nephropathy (HIVAN). HIV infection has also been associated with other forms of kidney disease, in particular, immune complex disease [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/2\">",
"     2",
"    </a>",
"    ]. With prolonged survival and aging of the population, HIV-infected patients are also at increasing risk for kidney disease due to comorbid conditions, such as diabetes and hypertension.",
"   </p>",
"   <p>",
"    Some of these disorders can result in end-stage renal disease (ESRD). Issues relating to HIV and dialysis will be reviewed here. HIV-related disorders of the kidney are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4168?source=see_link\">",
"     \"Overview of kidney disease in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/3/2104?source=see_link\">",
"     \"HIV-associated nephropathy (HIVAN)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of HIV infection in dialysis patients varies based on the demographics of the local ESRD population:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HIV-seropositivity has been reported in nearly 20 percent of dialysis patients in some urban centers with high HIV seroprevalence [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/3,4\">",
"       3,4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dialysis centers in suburban communities or those with a lower percentage of minority patients may have few or no HIV-infected patients [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Prevalence based upon a diagnosis of HIV infection or HIVAN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Using data available from the United States Renal Data System (USRDS), 800 to 900 new cases of ESRD are attributed to HIVAN (\"AIDS nephropathy\") each year in the US, predominantly among blacks [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/6\">",
"     6",
"    </a>",
"    ]. While the annual incidence of ESRD attributed to HIVAN has remained relatively stable, the prevalence continues to rise with increases in patient survival [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The true prevalence of HIVAN in ESRD patients is difficult to determine. Definitive diagnosis is available only for individuals who have undergone kidney biopsy, since many patients with suspected HIVAN will have another diagnosis on biopsy. As an example, one study of HIV-infected patients with a clinical presentation suggestive of HIVAN confirmed classic HIVAN on biopsy in only 65 percent (88 of 136 patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/3/2104?source=see_link\">",
"     \"HIV-associated nephropathy (HIVAN)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prevalence of HIV infection in dialysis patients may also be underestimated because of underreporting and failure to track HIV infection as a specific diagnostic category. Compared with an extensive dialysis chart review, one study reported an 83 percent sensitivity for the diagnosis of HIV infection using data reported on the HCFA 2728 form, which is used to collect data for the USRDS [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/8\">",
"     8",
"    </a>",
"    ]. The current version of the HCFA 2728 form no longer collects data on HIV status unless ESRD is attributed to HIVAN.",
"   </p>",
"   <p>",
"    Data from the Veterans Affairs healthcare system and from the Johns Hopkins HIV cohort have demonstrated a striking disparity in the risk of ESRD among HIV-positive blacks, who may have as much as a 30-fold increase in the risk of ESRD compared to HIV-positive whites [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. In the Veterans Affairs cohort, the risk of ESRD among HIV-positive blacks was similar to that observed among diabetics [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/9\">",
"     9",
"    </a>",
"    ]. Genetic variability at the MYH9 and APOL1 loci on chromosome 22 appears to account for a significant proportion of the racial disparity in ESRD risk, including the risk of HIVAN and other forms of FSGS [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/6/41066?source=see_link&amp;anchor=H9804961#H9804961\">",
"     \"Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis\", section on 'FSGS in African Americans'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Prevalence based upon HIV testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of HIV infection among dialysis patients as determined by serology",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    polymerase chain reaction (PCR) is also unclear. As previously mentioned, HIV seroprevalence varies by community and local demographic features, ranging from 0 to 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition, there is no consensus regarding HIV testing in the dialysis population (only 37 percent of dialysis centers reported routine testing for HIV infection in 2001 [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/5\">",
"     5",
"    </a>",
"    ]), making it difficult to obtain nationally representative data.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     HIV TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend voluntary confidential HIV testing of all dialysis patients [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/3,15,16\">",
"     3,15,16",
"    </a>",
"    ]. Potential clinical benefits of routine screening include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Improved patient survival with the use of combination antiretroviral therapy (ART) (see below)",
"     </li>",
"     <li>",
"      Therapeutic intervention with the potential to reverse HIVAN, including discontinuation of dialysis [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/17,18\">",
"       17,18",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Implementation of measures to prevent transmission to partners",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     False-positive results",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV testing initially involves testing plasma with an enzyme immunosorbent assay (EIA) for HIV-specific antibodies. Positive results are subsequently verified with Western blot testing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20345?source=see_link\">",
"     \"Diagnostic assays for HIV infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Compared with low risk patient populations without ESRD, routine HIV testing in patients with ESRD has been associated with an increased incidence of false-positive EIA and intermediate-positive Western blot results:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HIV testing in the hemodialysis population has been associated with widely varying rates (0.5 to 8.8 percent) of false-positive EIA results [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/19-23\">",
"       19-23",
"      </a>",
"      ]. Newer assays may be associated with a lower false-positive rate, although data are limited [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In an Israeli study, both false-positive EIA and indeterminate Western blot were found in 23 of 520 hemodialysis patients (4.4 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    False-positive results are thought to result from the presence of cross-reacting antibodies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The false-positive EIA phenomenon has been attributed to the presence of class II HLA cross-reacting antibodies against CD4+ T lymphocytes, based on data in the H-9 human T-cell line [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In one study, patients with intermediate Western blot results had cross-reacting antibodies against p24 and p55 HIV antigens [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A case report of a patient with a false-positive EIA and Western blot noted cross-reacting antibodies to a number of viral proteins, including p17, p24, p31, gp41, p51, p55, p66, gp120, and gp160 [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    By comparison, among patients with normal kidney function, false-positive EIA and intermediate Western blot tests occur as a result of cross-reacting antibodies due to vaccination, liver disease, or autoimmune disease [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20345?source=see_link\">",
"     \"Diagnostic assays for HIV infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the setting of a positive or indeterminate Western blot result, a confirmatory HIV plasma RNA should be performed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/44/39623?source=see_link\">",
"     \"Techniques and interpretation of HIV-1 RNA quantitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TRANSMISSION IN THE DIALYSIS UNIT",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV transmission in the dialysis setting, which is rare, can be avoided by strict adherence to standard infection control procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/26\">",
"     26",
"    </a>",
"    ]. Transmission of the hepatitis B virus poses a much greater risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Dialysis isolation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Center for Disease Control and Prevention (CDC) does not recommend routine isolation or dedicated machines for HIV-infected patients undergoing hemodialysis, given the low likelihood of patient-to-patient",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    patient-to-staff transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/27\">",
"     27",
"    </a>",
"    ]. As long as health care workers follow dialysis unit precautions, originally developed to prevent hepatitis B outbreaks, we also feel that no special isolation of HIV-positive dialysis patients is necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Patient-to-patient transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, patient-to-patient transmission of HIV infection has not been reported in a dialysis unit [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/28\">",
"     28",
"    </a>",
"    ]. However, at least four well-documented outbreaks of patient-to-patient HIV transmission have occurred since 1990 in hemodialysis units outside of the United States, including Argentina (two centers), Colombia, and Egypt [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. Seroconversion was documented in 9 of 13 patients in the Colombian unit and 24 of 39 patients in the Egyptian center. When compared with HIV-infected local controls, nucleotide sequence analyses in nearly half of these cases were consistent with a common source of exposure.",
"   </p>",
"   <p>",
"    The most likely causes of transmission were breaches in infection control protocol; however, no single activity could be implicated. Possibilities included reuse of the dialyzer, blood lines, and needles for different patients; the use of a weak chemical germicide (benzalkonium chloride) to reprocess needles; contamination of the ports connecting the dialysis machine to the blood lines; and the use of a contaminated multidose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    vial.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Needlestick transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of HIV seroconversion after a needlestick injury is estimated to be 3 in 1000 or 0.3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/32\">",
"     32",
"    </a>",
"    ]. Patient-to-healthcare worker transmission of HIV infection in the dialysis unit occurred in one documented needle-stick exposure in the United States between 1991 and 1993 [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/33\">",
"     33",
"    </a>",
"    ]. By comparison, the estimated risk of transmission after a similar event is 6 to 30 percent and 2 percent for hepatitis B and C virus, respectively. The larger the blood inoculum, the deeper the percutaneous injury, and the later the stage of HIV infection in the source patient, the greater the risk of HIV transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postexposure prophylaxis with antiretroviral therapy should be offered to exposed healthcare workers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7930?source=see_link\">",
"     \"Management of healthcare personnel exposed to HIV\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Education of all healthcare workers, staff, and trainees in standard infection control procedures and needlestick protocols is essential. Although rare, documented patient-to-patient and patient-to-healthcare worker HIV transmission in the dialysis environment makes routine HIV screening valuable in detecting outbreaks and assisting in the decision to initiate postexposure prophylaxis. Adherence to dialysis unit precautions should minimize the risk of HIV transmission.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Viral levels in ultrafiltrate",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a paucity of evidence relating to the presence or absence of HIV in hemodialysis ultrafiltrate. In one study of 10 ART-treated patients, slightly lower levels of virus were detected in blood post-hemodialysis as compared to predialysis levels [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/35\">",
"     35",
"    </a>",
"    ]; however, no viral RNA was detectable in the ultrafiltrate. The authors hypothesized that the absence of HIV in the ultrafiltrate could be explained by viral adherence to the dialysis membrane.",
"   </p>",
"   <p>",
"    HIV virus that is capable of replication is recoverable from peritoneal dialysis (PD) effluent [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. One study found that HIV was recoverable at room temperature for up to seven days in PD drainage bags and up to 48 hours from dry tubing [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/38\">",
"     38",
"    </a>",
"    ]. No difference in viral recovery was demonstrated between 1.5, 2.5, and 4.25 percent dextrose solutions. Because survival of replication-competent HIV requires an intracellular environment, the presence of peritonitis may increase the duration of HIV viability within PD effluent.",
"   </p>",
"   <p>",
"    The clinical significance of replication-competent HIV in the PD effluent is unknown. Although no case of HIV transmission via PD effluent has been described, the fluid poses a theoretical biological risk to disposal workers and medical personnel. Dilutions to 1:512 of both 10 percent bleach and 50 percent amukin are effective in preventing HIV recoverability in vitro [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/38\">",
"     38",
"    </a>",
"    ], while household bleach is too dilute to serve as a disinfectant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ISSUES RELATED TO DIALYSIS MODALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no evidence to suggest that one dialysis modality is superior; and both hemodialysis and peritoneal dialysis should be considered in HIV-infected individuals approaching ESRD [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/26,39\">",
"     26,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are several issues unique to the specific dialysis modality utilized among patients infected with HIV. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hemodialysis access infections and complications",
"     </li>",
"     <li>",
"      Dialyzer reuse",
"     </li>",
"     <li>",
"      Peritonitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Hemodialysis access infections and complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Retrospective series have demonstrated a significant increase in arteriovenous graft (AVG) infections and thrombosis in HIV-positive patients, a finding not observed with arteriovenous fistulae (AVF) [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. Unfortunately, studies of hemodialysis access in HIV patients are confounded by the disproportionate inclusion of injection drug users (IDU). Complication rates are higher in IDU as a result of sclerosis of upper extremity veins and active drug abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/40,43\">",
"     40,43",
"    </a>",
"    ], making it difficult to distinguish effects of HIV from those of IDU. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/15/12536?source=see_link\">",
"     \"Non-thrombotic complications of chronic hemodialysis arteriovenous vascular access\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because of the reported increase in infection and thrombosis with AVG, early AVF insertion in all HIV-infected hemodialysis patients has been recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/40,41,44\">",
"     40,41,44",
"    </a>",
"    ]. When an AVF is not technically feasible, we advocate insertion of an AVG rather than a tunneled cuffed catheter, since the latter confers an even higher infection rate regardless of HIV status [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/15/12536?source=see_link\">",
"     \"Non-thrombotic complications of chronic hemodialysis arteriovenous vascular access\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Dialyzer reuse",
"    </span>",
"    &nbsp;&mdash;&nbsp;The CDC recommendations that the care of HIV-infected hemodialysis patients include routine dialysis unit precautions, with optional reuse of the dialyzer by the same patient [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/27\">",
"     27",
"    </a>",
"    ]. Although we also consider such sterilization procedures to be adequate, many units prefer not to use reprocessed dialyzers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/59/7096?source=see_link\">",
"     \"Reuse of dialyzers\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Peritonitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of peritonitis in HIV-infected patients on chronic PD has varied in different studies. In several reports, a higher incidence of Pseudomonas and fungal peritonitis was reported in HIV-infected PD patients than in seronegative patients [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. Most of the patients required catheter removal to successfully treat the infection. Unusual organisms such as Pasteurella multocida, Trichosporon beigelii, Corynebacteria JK, and Mycobacterium avium complex have also been implicated in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/50-53\">",
"     50-53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/11/17594?source=see_link\">",
"     \"Microbiology and therapy of peritonitis in continuous peritoneal dialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other studies have reported peritonitis rates comparable to that of the general ESRD population [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. In two retrospective studies using HIV-uninfected PD patients as controls, HIV infection did not increase the rate of nosocomial or polymicrobial peritonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/56,57\">",
"     56,57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The differences in the reported rates of peritonitis may be related to disparities in the risk factors for HIV infection encountered in different centers [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/48,54\">",
"     48,54",
"    </a>",
"    ]. One study, for example, showed a similar rate of peritonitis in HIV-positive individuals and HIV-negative individuals at high risk for HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     ANEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia in HIV-infected ESRD patients is frequently multifactorial and may result from erythropoietin deficiency, opportunistic infections, and drug-induced myelosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/1/3098?source=see_link\">",
"     \"Hematologic manifestations of HIV infection: Anemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33496?source=see_link\">",
"     \"Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=see_link\">",
"     \"Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     ANTIRETROVIRAL THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of ART is the single most important intervention for an HIV-infected patient with ESRD. A detailed discussion of the use of ART in HIV-infected patients can be found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36234?source=see_link\">",
"     \"Selecting antiretroviral regimens for the treatment naive HIV-infected patient\"",
"    </a>",
"    .) Observational data suggest that ART is beneficial in HIVAN, including cases with dialysis-dependent renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/17,18,59\">",
"     17,18,59",
"    </a>",
"    ]. In two case reports, patients with HIVAN and dialysis-dependent renal failure became dialysis-free after initiating ART [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Repeat kidney biopsy also revealed significant histologic recovery in both cases. In December 2007, the Department of Health and Human Services modified the HIV treatment guidelines to include HIVAN as an indication for the initiation of ART, regardless of CD4 levels [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to the potential benefits for individuals with HIVAN, ART also provides substantial survival benefits among HIV-positive ESRD patients [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/61-66\">",
"     61-66",
"    </a>",
"    ], as discussed in detail below.",
"   </p>",
"   <p>",
"    The selection and dosing of antiretroviral drugs in patients with renal failure is discussed in detail separately. Inappropriate dosing of ART is common in dialysis patients and may be associated with inadequate virologic control, medication toxicity, and increased mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12759?source=see_link\">",
"     \"Dose modification of antiretroviral agents in adults with renal or hepatic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mortality among HIV-infected dialysis patients most closely correlates with the course of HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/47,54,69-71\">",
"     47,54,69-71",
"    </a>",
"    ]. Improved survival is associated with an earlier stage of HIV infection at the initiation of renal replacement therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/54,69\">",
"     54,69",
"    </a>",
"    ], younger age [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/54\">",
"     54",
"    </a>",
"    ], higher CD4 counts [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/54,70\">",
"     54,70",
"    </a>",
"    ], and ART use [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In reports from the 1980s, the mortality of AIDS patients treated with dialysis was extremely high, approaching 100 percent at one year [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/69\">",
"     69",
"    </a>",
"    ]. By comparison, subsequent studies reported greatly improved survival of HIV-infected dialysis patients after the introduction of ART [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/62-65\">",
"     62-65",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Based upon USRDS data, the survival of 6166 HIV-infected dialysis patients was assessed for the period 1990 to 1999 [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/63\">",
"       63",
"      </a>",
"      ]. The one-year survival improved from 56 percent among those who initiated dialysis in 1990 to 74 percent among patients who started in 1999. Information was not available concerning the use of ART, HIV viral load, and CD4 count.",
"     </li>",
"     <li>",
"      In a study of African-American dialysis patients from the USRDS, one-year survival increased from 47 percent during 1990 to 1994 to 65 percent during 1995 to 2001 [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/64\">",
"       64",
"      </a>",
"      ]; five-year survival also increased from 13 to 30 percent.",
"     </li>",
"     <li>",
"      A prospective cohort study from France reported similar survival (approximately 89 percent) among 164 HIV-infected hemodialysis patients and 584 hemodialysis patients without HIV or diabetes [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/65\">",
"       65",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In contrast, a large single-center cohort study of African-American ESRD patients in Baltimore, Maryland failed to demonstrate an improvement in survival with the advent of ART, likely reflecting inadequate antiretroviral treatment in this urban population [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/72\">",
"       72",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Long-term exposure to ART has been associated with an increased risk of cardiovascular disease in HIV-positive dialysis patients [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/73\">",
"     73",
"    </a>",
"    ]. Regimens containing protease inhibitors and nucleoside reverse transcriptase inhibitors (NRTI), in particular, have been associated with metabolic abnormalities and endothelial dysfunction, and increasing exposure to specific agents has been associated with an increased risk of myocardial infarction in large cohort studies [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/74-78\">",
"     74-78",
"    </a>",
"    ]. While the NRTI",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/63/31734?source=see_link\">",
"     abacavir",
"    </a>",
"    has received the most attention [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/75,76,78\">",
"     75,76,78",
"    </a>",
"    ], pooled data from pre-marketing clinical trials of abacavir did not demonstrate any excess risk [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/79\">",
"     79",
"    </a>",
"    ], and data from a large collaborative cohort study has also implicated several other ART agents [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34344/abstract/77\">",
"     77",
"    </a>",
"    ]. The potential for additive cardiovascular risk in ESRD patients should be balanced against the known benefits of ART.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     TRANSPLANTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;With improved survival and better long-term prognosis, kidney transplantation has emerged as an important consideration in HIV-positive patients with ESRD. The potential for significant interactions between calcineurin inhibitors and ART requires close communication between the transplant team and HIV providers. Kidney transplantation in patients with HIV infection is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/61/15321?source=see_link\">",
"     \"Solid organ transplantation in HIV-infected individuals\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The prevalence of human immunodeficiency virus (HIV) infection in dialysis patients varies in part based on the demographics of the local end-stage renal disease (ESRD) population as well as how the diagnosis of HIV infection was achieved. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend voluntary confidential HIV testing of all dialysis patients. Potential benefits of routine screening include improved patient survival, possible reversal of HIV associated nephropathy (HIVAN), and implementation of measures to prevent transmission to partners. However, compared with low risk patient populations, routine HIV testing in patients with ESRD may be associated with an increased incidence of false-positive results. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'HIV testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HIV transmission in the dialysis setting, which is rare, can be avoided by strict adherence to standard infection control procedures. In agreement with the Center for Disease Control and Prevention (CDC), we feel that no special isolation of HIV-positive dialysis patients is necessary. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Transmission in the dialysis unit'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The use of antiretroviral therapy (ART) is the single most important intervention for an HIV-infected patient with ESRD. ART is associated with the reversal of HIVAN and with decreased mortality in dialysis patients. However, inappropriate dosing of ART is common in dialysis patients and may be associated with inadequate virologic control or with medication toxicity. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Antiretroviral therapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Prognosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12759?source=see_link\">",
"       \"Dose modification of antiretroviral agents in adults with renal or hepatic dysfunction\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/1\">",
"      Wyatt CM, Winston JA, Malvestutto CD, et al. Chronic kidney disease in HIV infection: an urban epidemic. AIDS 2007; 21:2101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/2\">",
"      Gerntholtz TE, Goetsch SJ, Katz I. HIV-related nephropathy: a South African perspective. Kidney Int 2006; 69:1885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/3\">",
"      Winston JA, Klotman PE. Are we missing an epidemic of HIV-associated nephropathy? J Am Soc Nephrol 1996; 7:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/4\">",
"      Perez G, Ortiz-Interian C, Lee H, et al. Human immunodeficiency virus and human T-cell leukemia virus type I in patients undergoing maintenance hemodialysis in Miami. Am J Kidney Dis 1989; 14:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/5\">",
"      Vigneau C, Guiard-Schmid JB, Tourret J, et al. The clinical characteristics of HIV-infected patients receiving dialysis in France between 1997 and 2002. Kidney Int 2005; 67:1509.",
"     </a>",
"    </li>",
"    <li>",
"     U.S. Renal Data System, 2009 Annual Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/7\">",
"      D'Agati V, Appel GB. Renal pathology of human immunodeficiency virus infection. Semin Nephrol 1998; 18:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/8\">",
"      Longenecker JC, Coresh J, Klag MJ, et al. Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 2000; 11:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/9\">",
"      Choi AI, Rodriguez RA, Bacchetti P, et al. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol 2007; 18:2968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/10\">",
"      Lucas GM, Mehta SH, Atta MG, et al. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 2007; 21:2435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/11\">",
"      Lucas GM, Lau B, Atta MG, et al. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis 2008; 197:1548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/12\">",
"      Kao WH, Klag MJ, Meoni LA, et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008; 40:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/13\">",
"      Kopp JB, Smith MW, Nelson GW, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/14\">",
"      Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/15\">",
"      Kimmel PL, Bosch JP, Vassalotti JA. Treatment of human immunodeficiency virus (HIV)-associated nephropathy. Semin Nephrol 1998; 18:446.",
"     </a>",
"    </li>",
"    <li>",
"     Delgado, C, Jain, C, Shah, R, et al. Barriers to HIV Testing in an Urban Dialysis Center. American Society of Nephrology Renal Week, San Francisco, November 2, 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/17\">",
"      Wali RK, Drachenberg CI, Papadimitriou JC, et al. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet 1998; 352:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/18\">",
"      Winston JA, Bruggeman LA, Ross MD, et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001; 344:1979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/19\">",
"      Peterman TA, Lang GR, Mikos NJ, et al. HTLV-III/LAV infection in hemodialysis patients. JAMA 1986; 255:2324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/20\">",
"      Ujhelyi E, F&uuml;st G, Illei G, et al. Different types of false positive anti-HIV reactions in patients on haemodialysis. Immunol Lett 1989; 22:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/21\">",
"      Arnow PM, Fellner S, Harrington R, Leuther M. False-positive results of screening for antibodies to human immunodeficiency virus in chronic hemodialysis patients. Am J Kidney Dis 1988; 11:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/22\">",
"      Vardinon N, Yust I, Katz O, et al. Anti-HIV indeterminate western blot in dialysis patients: a long-term follow-up. Am J Kidney Dis 1999; 34:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/23\">",
"      Chou CC, Sun CY, Wu MS. Human immunodeficiency virus (HIV) infection screening in a dialysis unit. Ren Fail 2007; 29:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/24\">",
"      Jindal R, Solomon M, Burrows L. False positive tests for HIV in a woman with lupus and renal failure. N Engl J Med 1993; 328:1281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/25\">",
"      Mylonakis E, Paliou M, Lally M, et al. Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches. Am J Med 2000; 109:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/26\">",
"      Ahuja TS, O'brien WA. Special issues in the management of patients with ESRD and HIV infection. Am J Kidney Dis 2003; 41:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/27\">",
"      Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 2001; 50(RR-5):1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/28\">",
"      Centers for Disease Control and Prevention (CDC). HIV transmission in a dialysis center--Colombia, 1991-1993. MMWR Morb Mortal Wkly Rep 1995; 44:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/29\">",
"      Dyer E. Argentinian doctors accused of spreading AIDS. BMJ 1993; 307:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/30\">",
"      Velandia M, Fridkin SK, C&aacute;rdenas V, et al. Transmission of HIV in dialysis centre. Lancet 1995; 345:1417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/31\">",
"      El Sayed NM, Gomatos PJ, Beck-Sagu&eacute; CM, et al. Epidemic transmission of human immunodeficiency virus in renal dialysis centers in Egypt. J Infect Dis 2000; 181:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/32\">",
"      Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med 1997; 102:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/33\">",
"      Gilbert DN, Bennett W. Patients with human immunodeficiency virus infection in the hemodialysis unit. How vulnerable are the caregivers? Arch Intern Med 1995; 155:1575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/34\">",
"      Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997; 337:1485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/35\">",
"      Ahuja TS, Niaz N, Velasco A, et al. Effect of hemodialysis and antiretroviral therapy on plasma viral load in HIV-1 infected hemodialysis patients. Clin Nephrol 1999; 51:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/36\">",
"      Breyer JA, Harbison MA. Isolation of human immunodeficiency virus from peritoneal dialysate. Am J Kidney Dis 1993; 21:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/37\">",
"      Scheel PJ Jr, Farzadegan H, Ford D, et al. Recovery of human immunodeficiency virus from peritoneal dialysis effluent. J Am Soc Nephrol 1995; 5:1926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/38\">",
"      Farzadegan H, Ford D, Malan M, et al. HIV-1 survival kinetics in peritoneal dialysis effluent. Kidney Int 1996; 50:1659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/39\">",
"      Ahuja TS, Collinge N, Grady J, Khan S. Is dialysis modality a factor in survival of patients with ESRD and HIV-associated nephropathy? Am J Kidney Dis 2003; 41:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/40\">",
"      Brock JS, Sussman M, Wamsley M, et al. The influence of human immunodeficiency virus infection and intravenous drug abuse on complications of hemodialysis access surgery. J Vasc Surg 1992; 16:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/41\">",
"      Curi MA, Pappas PJ, Silva MB Jr, et al. Hemodialysis access: influence of the human immunodeficiency virus on patency and infection rates. J Vasc Surg 1999; 29:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/42\">",
"      Mitchell D, Krishnasami Z, Young CJ, Allon M. Arteriovenous access outcomes in haemodialysis patients with HIV infection. Nephrol Dial Transplant 2007; 22:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/43\">",
"      Nannery WM, Stoldt HS, Fares LG 2nd. Hemodialysis access operations performed upon patients with human immunodeficiency virus. Surg Gynecol Obstet 1991; 173:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/44\">",
"      Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40:1559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/45\">",
"      Mitchell D, Krishnasami Z, Allon M. Catheter-related bacteraemia in haemodialysis patients with HIV infection. Nephrol Dial Transplant 2006; 21:3185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/46\">",
"      Obialo CI, Robinson T, Brathwaite M. Hemodialysis vascular access: variable thrombus-free survival in three subpopulations of black patients. Am J Kidney Dis 1998; 31:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/47\">",
"      Tebben JA, Rigsby MO, Selwyn PA, et al. Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis. Kidney Int 1993; 44:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/48\">",
"      Dressler R, Peters AT, Lynn RI. Pseudomonal and candidal peritonitis as a complication of continuous ambulatory peritoneal dialysis in human immunodeficiency virus-infected patients. Am J Med 1989; 86:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/49\">",
"      Lewis M, Gorban-Brennan NL, Kliger A, et al. Incidence and spectrum of organisms causing peritonitis in HIV positive patients on CAPD. Adv Perit Dial 1990; 6:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/50\">",
"      Elsey RM, Carson RW, DuBose TD Jr. Pasteurella multocida peritonitis in an HIV-positive patient on continuous cycling peritoneal dialysis. Am J Nephrol 1991; 11:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/51\">",
"      Parsonnet J. Trichosporon beigelii peritonitis. South Med J 1989; 82:1062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/52\">",
"      Varela MP, Lew SQ, Smith AM, et al. Outcome of an opportunistic infection after polymicrobial peritonitis in an HIV-infected patient treated with peritoneal dialysis. Am J Nephrol 1999; 19:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/53\">",
"      Perazella M, Eisen T, Brown E. Peritonitis associated with disseminated Mycobacterium avium complex in an acquired immunodeficiency syndrome patient on chronic ambulatory peritoneal dialysis. Am J Kidney Dis 1993; 21:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/54\">",
"      Kimmel PL, Umana WO, Simmens SJ, et al. Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with end-stage renal disease. Kidney Int 1993; 44:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/55\">",
"      Wasser, WG, Boyle, MJ, Brandon, S, et al. HIV positivity does not predispose peritoneal dialysis patients to peritonitis. J Am Soc Nephrol 1991; 2:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/56\">",
"      Troidle L, Kliger AS, Goldie SJ, et al. Continuous peritoneal dialysis-associated peritonitis of nosocomial origin. Perit Dial Int 1996; 16:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/57\">",
"      Kiernan L, Finkelstein FO, Kliger AS, et al. Outcome of polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1995; 25:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/58\">",
"      Shrivastava D, Rao TK, Sinert R, et al. The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis. Am J Kidney Dis 1995; 25:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/59\">",
"      Klotman PE. HIV-associated nephropathy. Kidney Int 1999; 56:1161.",
"     </a>",
"    </li>",
"    <li>",
"     Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. November 3, 2008; 1-139. Available at file://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf (Accessed on November 20, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/61\">",
"      Ahuja TS, Borucki M, Grady J. Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients. Am J Kidney Dis 2000; 36:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/62\">",
"      Ifudu O, Mayers JD, Matthew JJ, et al. Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: has the outcome changed in the 1990s? Am J Kidney Dis 1997; 29:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/63\">",
"      Ahuja TS, Grady J, Khan S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol 2002; 13:1889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/64\">",
"      Macrae J, Friedman AL, Eggers P, Friedman EA. Improved survival in HIV-infected African-Americans with ESRD. Clin Nephrol 2005; 64:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/65\">",
"      Tourret J, Tostivint I, du Montcel ST, et al. Outcome and prognosis factors in HIV-infected hemodialysis patients. Clin J Am Soc Nephrol 2006; 1:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/66\">",
"      Trull&agrave;s JC, Cofan F, Barril G, et al. Outcome and prognostic factors in HIV-1-infected patients on dialysis in the cART era: a GESIDA/SEN cohort study. J Acquir Immune Defic Syndr 2011; 57:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/67\">",
"      Tourret J, Tostivint I, T&eacute;zenas Du Montcel S, et al. Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis. Clin Infect Dis 2007; 45:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/68\">",
"      Choi AI, Rodriguez RA, Bacchetti P, et al. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis 2007; 45:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/69\">",
"      Ortiz C, Meneses R, Jaffe D, et al. Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int 1988; 34:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/70\">",
"      Perinbasekar S, Brod-Miller C, Pal S, Mattana J. Predictors of survival in HIV-infected patients on hemodialysis. Am J Nephrol 1996; 16:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/71\">",
"      Dave MB, Shabih K, Blum S. Maintenance hemodialysis in patients with HIV-associated nephropathy. Clin Nephrol 1998; 50:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/72\">",
"      Atta MG, Fine DM, Kirk GD, et al. Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. Clin Infect Dis 2007; 45:1625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/73\">",
"      Oberai PC, Dalal D, Zhang L, et al. Incidence of atherosclerotic cardiovascular disease among HIV patients receiving dialysis. Am J Kidney Dis 2006; 47:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/74\">",
"      Tsiodras S, Mantzoros C, Hammer S, Samore M. Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study. Arch Intern Med 2000; 160:2050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/75\">",
"      Strategies for Management of Anti-Retroviral Therapy/INSIGHT, DAD Study Groups. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients. AIDS 2008; 22:F17.",
"     </a>",
"    </li>",
"    <li>",
"     D:A:D Study Group, Sabin, CA, Worm, SW, et al. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 2008: 37:1417.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/77\">",
"      Worm SW, Sabin C, Weber R, et al. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. J Infect Dis 2010; 201:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/78\">",
"      Obel N, Farkas DK, Kronborg G, et al. Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study. HIV Med 2010; 11:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34344/abstract/79\">",
"      Brothers CH, Hernandez JE, Cutrell AG, et al. Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline-sponsored clinical trials in adult subjects. J Acquir Immune Defic Syndr 2009; 51:20.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1915 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-E57427EB1A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34344=[""].join("\n");
var outline_f33_34_34344=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Prevalence based upon a diagnosis of HIV infection or HIVAN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Prevalence based upon HIV testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      HIV TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      False-positive results",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TRANSMISSION IN THE DIALYSIS UNIT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Dialysis isolation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Patient-to-patient transmission",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Needlestick transmission",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Viral levels in ultrafiltrate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ISSUES RELATED TO DIALYSIS MODALITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Hemodialysis access infections and complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Dialyzer reuse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Peritonitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      ANEMIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      ANTIRETROVIRAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      TRANSPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20345?source=related_link\">",
"      Diagnostic assays for HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12759?source=related_link\">",
"      Dose modification of antiretroviral agents in adults with renal or hepatic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/6/41066?source=related_link\">",
"      Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33496?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/3/2104?source=related_link\">",
"      HIV-associated nephropathy (HIVAN)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/1/3098?source=related_link\">",
"      Hematologic manifestations of HIV infection: Anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7930?source=related_link\">",
"      Management of healthcare personnel exposed to HIV",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/11/17594?source=related_link\">",
"      Microbiology and therapy of peritonitis in continuous peritoneal dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/15/12536?source=related_link\">",
"      Non-thrombotic complications of chronic hemodialysis arteriovenous vascular access",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4168?source=related_link\">",
"      Overview of kidney disease in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/59/7096?source=related_link\">",
"      Reuse of dialyzers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36234?source=related_link\">",
"      Selecting antiretroviral regimens for the treatment naive HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/61/15321?source=related_link\">",
"      Solid organ transplantation in HIV-infected individuals",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/44/39623?source=related_link\">",
"      Techniques and interpretation of HIV-1 RNA quantitation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_34_34345="Classic Kaposi sarcoma - patches and plaques";
var content_f33_34_34345=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F81468%7EDERM%2F69584%7EDERM%2F54707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F81468%7EDERM%2F69584%7EDERM%2F54707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Classic Kaposi sarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple red-brown patches and plaques are present on the lower leg.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Classic Kaposi sarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple violaceous papules and plaques are present on the distal upper extremity of this patient with classic Kaposi sarcoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Classic Kaposi sarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple papules and nodules are present on the lower leg in this patient with classic Kaposi sarcoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34345=[""].join("\n");
var outline_f33_34_34345=null;
var title_f33_34_34346="Approach to the adult patient with splenomegaly and other splenic disorders";
var content_f33_34_34346=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the adult patient with splenomegaly and other splenic disorders",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?33/34/34346/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?33/34/34346/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?33/34/34346/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?33/34/34346/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?33/34/34346/contributors\">",
"     William C Mentzer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?33/34/34346/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?33/34/34346/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?33/34/34346/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 30, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spleen is a hematopoietic organ capable of supporting elements of the erythroid, myeloid, megakaryocytic, lymphoid, and monocyte-macrophage (ie, reticuloendothelial) systems [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/1\">",
"     1",
"    </a>",
"    ]. As such, it is important in the following situations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The spleen participates in cellular and humoral immunity through its lymphoid elements. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6056?source=see_link\">",
"       \"The adaptive cellular immune response\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27624?source=see_link\">",
"       \"The humoral immune response\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The spleen is involved with the removal of senescent red blood cells, bacteria, and other particulates from the circulation through elements of the monocyte-macrophage system. An increase in this function (ie, hypersplenism) may be associated with varying degrees of cytopenia, while removal of the spleen may render the patient susceptible to bacterial sepsis, especially with encapsulated organisms [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/62/9194?source=see_link&amp;anchor=H28#H28\">",
"       \"Extrinsic nonimmune hemolytic anemia due to mechanical damage: Fragmentation hemolysis and hypersplenism\", section on 'Extravascular nonimmune hemolysis due to hypersplenism'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/42/9895?source=see_link\">",
"       \"Clinical features and management of sepsis in the asplenic patient\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Splenectomy in patients with various hematologic disorders (eg, polycythemia vera, essential thrombocythemia, thalassemia, stomatocytosis) has been associated with an increased incidence of vascular complications, including venous and arterial thrombosis and pulmonary hypertension [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/2,3\">",
"       2,3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Normally, about one-third of circulating platelets are sequestered in the spleen, where they are in equilibrium with circulating platelets. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/19/15674?source=see_link&amp;anchor=H10#H10\">",
"       \"Approach to the adult patient with thrombocytopenia\", section on 'Dilutional thrombocytopenia'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/19/15674?source=see_link&amp;anchor=H11#H11\">",
"       \"Approach to the adult patient with thrombocytopenia\", section on 'Distributional thrombocytopenia caused by splenomegaly'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Under abnormal circumstances (eg, primary myelofibrosis), the spleen may become the site of extramedullary hematopoiesis and contain developing erythroid, myeloid, and megakaryocytic precursors. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/63/1018?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical manifestations and diagnosis of primary myelofibrosis\", section on 'Extramedullary hematopoiesis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic review will discuss the approach to a patient whose spleen is enlarged on physical examination (ie, splenomegaly) or is more than minimally enlarged on ultrasound, x-ray, nuclear medicine liver-spleen colloid study, CT scan, or magnetic resonance imaging. However, it should be remembered that the diagnostic criteria for various disease states have historically been built on long experience with the physical examination, while scanning procedures have been available for a shorter period of time. Thus, the clinical or diagnostic significance of a spleen that is modestly enlarged on scan but is not palpable (ie, \"scanomegaly\") is uncertain.",
"   </p>",
"   <p>",
"    As an example, in polycythemia vera, palpable splenomegaly was a major diagnostic criterion according to the Polycythemia Vera Study Group. However, a spleen enlarged on a scanning procedure has been considered to be only a minor criterion using other diagnostic algorithms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9738?source=see_link\">",
"     \"Diagnostic approach to the patient with suspected polycythemia vera\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An approach to the child with splenomegaly is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/34/12840?source=see_link\">",
"     \"Approach to the child with an enlarged spleen\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SPLENIC DISORDERS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Normal splenic function",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spleen lies within the peritoneal cavity in the posterior portion of the left upper quadrant, below the diaphragm and adjacent to the 9th to the 11th ribs, stomach, colon, and left kidney, with its hilum in close approximation to the tail of the pancreas. The spleen weighs 80 to 200 grams and 70 to 180 grams in the normal adult male and female, respectively, averaging about 150 grams, or approximately 0.2 percent of body weight [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/4\">",
"     4",
"    </a>",
"    ]. It is not usually palpable, but may be felt in children, adolescents, and some adults, especially those of asthenic build.",
"   </p>",
"   <p>",
"    The spleen is a major lymphopoietic organ, containing approximately 25 percent of the total lymphoid mass of the body; this component, as well as components of the monocyte-macrophage system, can react and enlarge quickly after the onset of infection or inflammation. Under such circumstances, a spleen enlarged to scan but not palpably enlarged may be a nonspecific marker of inflammation similar to an elevated erythrocyte sedimentation rate or other acute phase reactants. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38569?source=see_link\">",
"     \"Acute phase reactants\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A major function of the spleen is to remove particulates (eg, opsonized bacteria, antibody-coated cells) from the blood stream [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/5\">",
"     5",
"    </a>",
"    ]. This function is most apparent when the spleen has been removed, since splenectomized patients are susceptible to bacterial sepsis, especially with encapsulated organisms. This function is also associated with trapping and destruction antibody-coated platelets or red cells in patients with autoimmune thrombocytopenia or hemolytic anemia, respectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/42/9895?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical features and management of sepsis in the asplenic patient\", section on 'Role of the spleen in host defense'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"./treatment-and-prognosis-of-immune-thrombocytopenia-itp-in-adults?source=see_link&amp;anchor=H17#H17\">",
"     \"Treatment and prognosis of immune thrombocytopenia (ITP) in adults\", section on 'Splenectomy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/62/14313?source=see_link&amp;anchor=H13#H13\">",
"     \"Treatment of autoimmune hemolytic anemia: Warm agglutinins\", section on 'Splenectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The spleen also serves as a quality control mechanism for red cells, removing senescent",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    poorly deformable red cells from the circulation. This \"culling\" function is taken advantage of when splenectomy is employed as treatment for hereditary spherocytosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/1/20506?source=see_link&amp;anchor=H10#H10\">",
"     \"Hereditary spherocytosis: Clinical features; diagnosis; and treatment\", section on 'Splenectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As part of this quality control function, the spleen also removes particles from within circulating red cells (ie, its \"pitting\" function), such as nuclear remnants (Howell-Jolly bodies), insoluble globin precipitates (Heinz bodies), and normally-occurring endocytic vacuoles. Of clinical importance, Howell-Jolly bodies",
"    <strong>",
"     appear",
"    </strong>",
"    in circulating red cells when the spleen has been surgically removed or has reduced function (ie, hyposplenism), and subsequently",
"    <strong>",
"     disappear",
"    </strong>",
"    when and if splenic function returns, as in the following circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Splenosis due to the growth of splenic implants resulting from the spillage of cells from the splenic pulp during splenectomy. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Splenosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Growth of preexisting accessory spleen(s) following splenectomy, classically (albeit rarely) described in patients with immune thrombocytopenia (ITP) or autoimmune hemolytic anemia (AIHA) undergoing a late relapse after successful splenectomy [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/6\">",
"       6",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"./chronic-refractory-immune-thrombocytopenia-itp-in-adults?source=see_link&amp;anchor=H22#H22\">",
"       \"Chronic refractory immune thrombocytopenia (ITP) in adults\", section on 'Accessory splenectomy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Improvement in splenic function, as seen in some patients with sickle cell anemia following successful allogeneic hematopoietic cell transplantation [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/7\">",
"       7",
"      </a>",
"      ] or institution of a chronic transfusion program in children or young adults [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/8,9\">",
"       8,9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Hypersplenism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normally, about one-third of the platelet mass is sequestered in the spleen, where it is in equilibrium with circulating platelets. Splenic sequestration of platelets can be increased to 90 percent in cases of extreme splenomegaly, although total platelet mass and overall platelet survival remain relatively normal (",
"    <a class=\"graphic graphic_figure graphicRef52400 \" href=\"UTD.htm?7/24/7566\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with cirrhosis, portal hypertension, and splenomegaly may have significant degrees of \"apparent\" thrombocytopenia (with or without leukopenia and anemia), but rarely have clinical bleeding, since their total platelet mass is usually normal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/62/9194?source=see_link&amp;anchor=H28#H28\">",
"     \"Extrinsic nonimmune hemolytic anemia due to mechanical damage: Fragmentation hemolysis and hypersplenism\", section on 'Extravascular nonimmune hemolysis due to hypersplenism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hyposplenism and asplenia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splenic functions are lost when the spleen is congenitally absent, has been surgically removed, has atrophied following repeated infarction (eg, sickle cell disease), or following splenic artery thrombosis.",
"   </p>",
"   <p>",
"    Splenic function is reduced in the neonate and may be abnormally reduced (called hyposplenism or functional asplenia) when it is engorged with blood (eg, splenic sequestration crisis associated with sickle cell disease, malaria, splenic vein thrombosis), or infiltrated (sarcoidosis, amyloidosis, tumors, cysts) [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/11-13\">",
"     11-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Functional asplenia has also been described in autoimmune disease, celiac disease, and inflammatory bowel disease; the mechanism in these latter settings is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/14-17\">",
"     14-17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40650?source=see_link&amp;anchor=H22#H22\">",
"     \"Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults\", section on 'Hyposplenism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Subjects with hyposplenism or",
"    <span class=\"nowrap\">",
"     functional/surgical",
"    </span>",
"    asplenia may show any or all of the following [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/17-19\">",
"     17-19",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42170?source=see_link&amp;anchor=H12679833#H12679833\">",
"     \"Overview of the clinical manifestations of sickle cell disease\", section on 'Reduced or absent splenic function'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sepsis with encapsulated organisms, especially in children. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/42/9895?source=see_link&amp;anchor=H4#H4\">",
"       \"Clinical features and management of sepsis in the asplenic patient\", section on 'Incidence'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mild degrees of thrombocytosis (",
"      <a class=\"graphic graphic_table graphicRef74148 \" href=\"UTD.htm?32/7/32892\">",
"       table 1",
"      </a>",
"      ) and leukocytosis.",
"     </li>",
"     <li>",
"      The presence of Howell-Jolly bodies in circulating red cells, increased numbers of target cells and misshapen red cells (",
"      <a class=\"graphic graphic_picture graphicRef60588 \" href=\"UTD.htm?38/45/39638\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef64449 \" href=\"UTD.htm?1/42/1703\">",
"       picture 2",
"      </a>",
"      ), and red cells with reduced deformability [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/20\">",
"       20",
"      </a>",
"      ]. Howell-Jolly bodies can be quantitated to provide an estimate of the degree of splenic hypofunction [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/21,22\">",
"       21,22",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38313?source=see_link&amp;anchor=H27#H27\">",
"       \"Evaluation of the peripheral blood smear\", section on 'Howell Jolly bodies'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Increased number of erythrocyte \"pits\" and Heinz bodies. Demonstration of these abnormalities requires special techniques such as interference microscopy and supravital dyes, respectively. Quantitation of the number of pitted erythrocytes has been used to estimate the volume and function of splenic tissue remaining after splenectomy [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Depending upon the degree of hypofunction, imaging studies may demonstrate decreased or absent uptake of radioactive colloid, red cells, white cells,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      platelets by the spleen [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/11-13,15\">",
"       11-13,15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Splenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splenic implants may result from the spillage of cells from the splenic pulp following injury or splenectomy, a condition called splenosis. These implants, which are often multiple, can be located anywhere in the peritoneal cavity, although they are most often found in the left upper quadrant of the abdomen, and may be confused with neoplasms or endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. If traumatic splenic rupture is accompanied by a diaphragmatic tear, implants can also be present within the pleural or pericardial cavities [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/27-29\">",
"     27-29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These implants, which consist of normal splenic tissue, can be diagnosed via tissue biopsy techniques or non-invasively through radioisotope scanning, using either Tc99m sulfur colloid or labeled, heat-denatured red cells [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. If the patient has had a prior splenectomy, a presumptive diagnosis of the presence of splenic implants can be made if the peripheral smear no longer shows the presence of Howell-Jolly bodies (see",
"    <a class=\"local\" href=\"#H5\">",
"     'Hyposplenism and asplenia'",
"    </a>",
"    above) [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Splenic abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splenic abscess is an uncommon infection that typically results from endocarditis or seeding from some other site of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/32-36\">",
"     32-36",
"    </a>",
"    ]. The frequency of this complication was evaluated in a review of 564 patients with documented endocarditis in whom 27 (4.8 percent) developed splenic abscess [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Typical clinical manifestations are fever that may be recurrent or persistent despite antimicrobial therapy and left upper quadrant pain with or without splenomegaly [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/33,34,36\">",
"     33,34,36",
"    </a>",
"    ]. However, some patients lack these classic features [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/37\">",
"     37",
"    </a>",
"    ]. Splenic abscess may be accompanied by a left-sided pleural effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/36\">",
"     36",
"    </a>",
"    ] or by splenic infarction if due to septic emboli [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A splenic abscess can usually be seen on CT scan [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/32,33\">",
"     32,33",
"    </a>",
"    ], although the lesion may be incorrectly called an infarct [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/33\">",
"     33",
"    </a>",
"    ] which also can be a complication of bacterial endocarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Symptoms'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Splenic abscess is usually managed by a combination of antibiotic therapy and splenectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/32-34,37\">",
"     32-34,37",
"    </a>",
"    ]. CT-guided percutaneous aspiration is occasionally successful, but this approach has not replaced splenectomy as the standard of care [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Splenic infarction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splenic infarction occurs when the splenic artery or one or more of its sub-branches become occluded with an infected or bland embolus or clot. Affected patients classically present with acute left upper quadrant pain and tenderness, although atypical presentations are common. As an example, in a study of 26 patients with splenic infarction seen at a single medical center, the following clinical and laboratory features were noted [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/38\">",
"     38",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Left-sided abdominal pain: 48 percent; abdominal pain was absent in 16 percent",
"     </li>",
"     <li>",
"      Fever &gt;38&deg;C: 36 percent",
"     </li>",
"     <li>",
"      Left upper quadrant abdominal tenderness: 36 percent; abdominal tenderness was absent in 32 percent",
"     </li>",
"     <li>",
"      Nausea or vomiting: 32 percent",
"     </li>",
"     <li>",
"      Splenomegaly: 32 percent",
"     </li>",
"     <li>",
"      Elevated serum lactate dehydrogenase (LDH): 71 percent",
"     </li>",
"     <li>",
"      White blood cell count",
"      <span class=\"nowrap\">",
"       &gt;12,000/microL:",
"      </span>",
"      56 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Splenic infarction can occur in a variety of settings [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/39\">",
"     39",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Presence of a hypercoagulable state (eg, malignancy, antiphospholipid syndrome) [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/40\">",
"       40",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Embolic disease (eg, atrial fibrillation, patent foramen ovale, atheromatous disease, infective endocarditis) [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/32,41,42\">",
"       32,41,42",
"      </a>",
"      ]. Splenic artery embolization has been therapeutically employed in order to reduce splenic blood flow in some patients with severe portal hypertension, prior to laparoscopic splenectomy in order to diminish intraoperative blood loss, as well as for the treatment of splenic injury [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/43\">",
"       43",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35465?source=see_link&amp;anchor=H14#H14\">",
"       \"Treatment of diuretic-resistant ascites in patients with cirrhosis\", section on 'Splenic artery embolization'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/1/20506?source=see_link&amp;anchor=H10#H10\">",
"       \"Hereditary spherocytosis: Clinical features; diagnosis; and treatment\", section on 'Splenectomy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Underlying myeloproliferative disorder with associated (often massive) splenomegaly (eg, polycythemia vera, essential thrombocythemia, primary myelofibrosis)",
"     </li>",
"     <li>",
"      Underlying hemoglobinopathy, especially sickle cell disease [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/44-46\">",
"       44-46",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/49/2842?source=see_link&amp;anchor=H8#H8\">",
"       \"Hepatic manifestations of sickle cell disease\", section on 'Computerized tomography'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H5\">",
"       'Hyposplenism and asplenia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Any condition associated with marked splenomegaly (eg, Gaucher disease, splenic lymphoma). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/11/9402?source=see_link&amp;anchor=H9#H9\">",
"       \"Gaucher disease: Pathogenesis, clinical manifestations, and diagnosis\", section on 'Visceral disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Trauma to the spleen which compromises its vascularity. Splenic hematoma and laceration may also occur following blunt abdominal trauma. This subject is discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/42/4777?source=see_link\">",
"       \"Liver, spleen, and pancreas injury in children with blunt abdominal trauma\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/42/4777?source=see_link&amp;anchor=H14482602#H14482602\">",
"       \"Liver, spleen, and pancreas injury in children with blunt abdominal trauma\", section on 'Spleen'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Splenic arterial torsion, as seen in the \"wandering spleen\" syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/30/16874?source=see_link&amp;anchor=H40#H40\">",
"       \"Differential diagnosis of abdominal pain in adults\", section on 'Wandering spleen syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Splenic infarction and splenic rupture are uncommon complications of infectious mononucleosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/55/14202?source=see_link&amp;anchor=H10#H10\">",
"       \"Clinical manifestations and treatment of Epstein-Barr virus infection\", section on 'Splenic rupture'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Splenic calcification and cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the increase in ultrasound and imaging procedures, patients are being referred who have abnormalities in splenic architecture that frequently have nothing to do with the patient's complaints. This has lead to patient anxiety and multiple extensive and repetitive further imaging studies at considerable expense and little apparent clinical benefit. Two such findings are splenic calcification and splenic cysts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Calcification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splenic calcification may be noted on conventional imaging techniques, and may or may not be associated with splenomegaly. A vast number of abnormal conditions may be associated with such calcifications, including phleboliths, splenic artery aneurysm, sickle cell disease [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/47\">",
"     47",
"    </a>",
"    ], tumors (eg, hemangioma, hemangiosarcoma, lymphoma), and infections (eg, histoplasmosis, brucellosis, echinococcosis, candidiasis, tuberculosis) [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/48-56\">",
"     48-56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gamna-Gandy bodies are fibro-siderotic nodules impregnated with iron pigment (hemosiderin) and calcium that may appear in the spleen in congestive splenomegaly, sickle cell anemia, and hemochromatosis [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/57\">",
"     57",
"    </a>",
"    ]. They likely represent areas of organized hemorrhage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Cysts and pseudocysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;A splenic cyst (or multiple cysts) may be noted as an incidental finding on conventional imaging techniques, or as a result of evaluation of a patient with left upper quadrant pain, left shoulder pain, abdominal enlargement, or splenomegaly. A vast number of abnormal conditions, many of which are rare, may be associated with such cysts, including [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Post-traumatic",
"      <span class=\"nowrap\">",
"       cysts/pseudocysts,",
"      </span>",
"      including cystic splenosis",
"     </li>",
"     <li>",
"      Hydatid (echinococcal) cysts",
"     </li>",
"     <li>",
"      Congenital cysts",
"     </li>",
"     <li>",
"      Epidermoid, mesothelial cysts",
"     </li>",
"     <li>",
"      Hemangioma, lymphangioma",
"     </li>",
"     <li>",
"      Polycystic kidney disease with splenic cysts",
"     </li>",
"     <li>",
"      Splenic peliosis",
"     </li>",
"     <li>",
"      Cystic metastasis to the spleen",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some splenic cysts may remain unchanged for many years, while others may enlarge slowly, enlarge to massive proportions, rupture, bleed, or become secondarily infected. Since non-parasitic splenic cysts are rare, there is no evidence-based information regarding their optimal surgical management [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For those with symptomatic cysts, or cysts that are enlarging over time, a number of radiologic and surgical procedures are available for investigating the probable diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/60-62\">",
"     60-62",
"    </a>",
"    ]. Available options for those with non-parasitic cysts include percutaneous procedures (eg, biopsy, aspiration, drainage), or more direct surgical interventions such as",
"    <span class=\"nowrap\">",
"     decapsulation/cyst",
"    </span>",
"    wall unroofing, partial or total splenectomy. However, only splenectomy provides diagnostic certainty, which is rarely clinically justified.",
"   </p>",
"   <p>",
"    Treatment of echinococcal cysts is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/58/27561?source=see_link\">",
"     \"Treatment of echinococcosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Splenic rupture",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Traumatic splenic rupture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blunt abdominal trauma most often results in injury to the spleen, which in over 60 percent of cases is the only damaged intraperitoneal structure. Delayed splenic rupture can occur. This subject is discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=see_link\">",
"       \"Initial evaluation and management of blunt abdominal trauma in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=see_link\">",
"       \"Management of splenic injury in the adult trauma patient\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7049?source=see_link\">",
"       \"Surgical management of splenic injury in the adult trauma patient\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19497?source=see_link\">",
"       \"Child abuse: Injuries of the thorax; abdomen; retroperitoneum; and pelvis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/42/4777?source=see_link&amp;anchor=H14482602#H14482602\">",
"       \"Liver, spleen, and pancreas injury in children with blunt abdominal trauma\", section on 'Spleen'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Atraumatic splenic rupture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splenic rupture in the absence of trauma is uncommon, but may be life-threatening. In a systematic review of 845 cases from the literature, in which the mortality was 12 percent, six major causes were described [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/63\">",
"     63",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Neoplasm (eg, leukemia, lymphoma) &mdash; 30 percent",
"     </li>",
"     <li>",
"      Infection (eg, infectious mononucleosis, CMV, HIV, endocarditis, malaria) &mdash; 27 percent",
"     </li>",
"     <li>",
"      Inflammatory",
"      <span class=\"nowrap\">",
"       disease/non-infectious",
"      </span>",
"      disorders (eg, acute and chronic pancreatitis, primary amyloidosis) &mdash; 20 percent",
"     </li>",
"     <li>",
"      Drug and treatment related (eg, anticoagulation, G-CSF, thrombolytic therapy, dialysis) &mdash; 9 percent",
"     </li>",
"     <li>",
"      Mechanical causes (eg, pregnancy-related, congestive splenomegaly) &mdash; 7 percent",
"     </li>",
"     <li>",
"      Idiopathic (normal spleen) &mdash; 7 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Risk factors for mortality included splenomegaly, age &gt;40 years, and the presence of a neoplastic disorder. Splenectomy was performed in 84 percent of the cases, with conservative measures taken in the remainder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7760030\">",
"    <span class=\"h2\">",
"     Splenic artery aneurysm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splenic artery aneurysms are the third most common aneurysms found within the abdomen, after those of the aorta and iliac arteries. They are clinically important because of the possibility of rupture, which is associated with a high mortality rate, especially during pregnancy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    in patients with portal hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. They are often calcified and may be mistaken for lesions of the distal pancreas [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/66\">",
"     66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22777?source=see_link&amp;anchor=H2#H2\">",
"     \"Pregnancy in women with pre-existing chronic liver disease\", section on 'Cirrhosis and portal hypertension'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/44/36554?source=see_link&amp;anchor=H15372650#H15372650\">",
"     \"Approach to abdominal pain and the acute abdomen in pregnant and postpartum women\", section on 'Disorders of the spleen'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment options include surgical resection with vascular reconstruction, stenting of the vessel or endovascular",
"    <span class=\"nowrap\">",
"     coil/glue",
"    </span>",
"    ablation techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/67-69\">",
"     67-69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence or absence of symptoms due to an enlarged spleen depends on many factors, such as the acuteness and nature of the underlying illness, as well as the size of the spleen. Thus, a minimally enlarged spleen secondary to an acute viral infection may be quite tender, while a markedly enlarged spleen in one of the chronic myeloproliferative disorders (eg, polycythemia vera, primary myelofibrosis) may be totally asymptomatic unless there is an episode of splenic infarction.",
"   </p>",
"   <p>",
"    When present, symptoms of an enlarged spleen may include one or all of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pain, a sense of fullness, or discomfort in the left upper quadrant",
"     </li>",
"     <li>",
"      Pain referred to the left shoulder",
"     </li>",
"     <li>",
"      Early satiety, due to encroachment on the adjacent stomach",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Acute pleuritic-like pain and tenderness in the left upper quadrant in the presence of fever suggests the presence of perisplenitis or splenic abscess, most likely due to infection originating elsewhere in the body (eg, sepsis, infective endocarditis). Splenic abscess may be accompanied by a left pleural effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/36\">",
"     36",
"    </a>",
"    ] or by splenic infarction if due to septic emboli [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/32\">",
"     32",
"    </a>",
"    ]. Some patients with splenic infarction have an associated friction rub over the infarcted area. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Splenic disorders'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/30/16874?source=see_link\">",
"     \"Differential diagnosis of abdominal pain in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2090715\">",
"    <span class=\"h1\">",
"     SPLENIC SIZE AND PALPABILITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The median splenic weight in adults is about 150 grams [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/4,70\">",
"     4,70",
"    </a>",
"    ]. It is not usually palpable, but may be felt in children, adolescents, and some adults, especially those of asthenic build [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/71\">",
"     71",
"    </a>",
"    ]. A spleen becomes palpable not only as a result of its size, but also its texture. Ordinarily, the spleen is a soft organ, but a spleen infiltrated with lymphoma or one with extramedullary hematopoiesis (eg, a myeloproliferative disorder) is much firmer and thus easier to feel. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Normal splenic function'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have shown wide interobserver variability in the ability to appreciate an enlarged spleen, which is generally not associated with the level of clinical experience [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/72\">",
"     72",
"    </a>",
"    ]. There are at least six different palpation and percussion maneuvers available. Only two of these will be discussed here: abdominal palpation and percussion of Traube's semilunar space. The interested reader is referred to the literature and textbooks of physical examination techniques for further information on this subject [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/42,72-74\">",
"     42,72-74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Palpation method",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most frequent errors made in examination of the spleen involve incomplete relaxation of the abdominal musculature of the patient and the musculature of the examiner's hand(s). Effectiveness in palpating the spleen can be maximized by remembering that the major error in splenic palpation is due to pressing too hard on the patient's abdomen, and by paying attention to the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With the patient supine, allow the patient to feel the examining hand on the abdomen before pressing down, and to become adjusted to its presence. Do not suddenly increase pressure during palpation, as an enlarged spleen may be quite tender (particularly if it has enlarged quickly) and the patient may be reluctant to allow the examination to continue.",
"     </li>",
"     <li>",
"      Make sure that the patient is relaxed, with arms at the sides of the abdomen. If the arms are raised, this may stiffen the abdominal musculature and make examination more difficult.",
"     </li>",
"     <li>",
"      Relaxation of the patient can be improved if the legs and neck are slightly flexed. Relaxation of the examiner can be improved by being comfortably seated in a chair alongside the patient's bed or examining table, with the examiner on the patient's right side, the right hand doing the palpation and the left hand underneath and supporting the patient's left lower posterior rib cage.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A spleen that is only minimally enlarged will be quite movable with respiration, and may be palpable only at the end of inspiration. Using a light touch, with the skin depressed under the left costal margin, a minimally enlarged spleen can be felt as a rounded edge with the consistency of normal liver, which slips under the examiner's fingers at the end of inspiration and back on expiration.",
"   </p>",
"   <p>",
"    Since the spleen is normally a posterior structure, increased sensitivity can occasionally be obtained by placing the patient in the right lateral decubitus position, with knees and neck flexed. This maneuver also increases relaxation of the abdominal musculature and rotates the spleen to a more anterior position. One study suggested that this additional maneuver was not useful when it followed examination of the patient in the supine position [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/42\">",
"     42",
"    </a>",
"    ]. However, it is this authors' experience that some spleens not palpable with the patient in the supine position are felt with the patient in the right lateral decubitus position.",
"   </p>",
"   <p>",
"    With greater degrees of enlargement, the spleen rotates to a more anterior and rightward position, and may extend downward into the pelvis. Under these circumstances, the lower pole of the spleen may not be easily felt (since it is well below the left costal margin), and splenomegaly is appreciated either by palpating at successively lower levels on the left side of the abdomen or by palpating the medial edge of the spleen. The presence of a notch or indentation on the medial splenic edge is a further indication that the mass is spleen and not the left kidney or a pancreatic pseudocyst.",
"   </p>",
"   <p>",
"    In more extreme cases, the enlarged spleen extends across the midline, and may even be palpable in the right upper quadrant. The presence of exquisite splenic tenderness suggests the presence of infarction or perisplenitis in such massively enlarged spleens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Percussion of Traube's semilunar space",
"    </span>",
"    &nbsp;&mdash;&nbsp;The tympanitic area overlying the gastric stomach bubble in the left lateral hemithorax has been called Traube's semilunar space [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/75\">",
"     75",
"    </a>",
"    ]. The size and location of this space depends upon the contents and position of the stomach. The space will be obliterated in the presence of left pleural or pericardial effusion, and will be displaced downward following enlargement of the left lobe of the liver or, more commonly, the spleen. False-positive and false-negative results may be obtained, however, in patients examined too soon after a meal and in obese subjects, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Accuracy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ability to palpate an enlarged spleen depends upon several variables, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The size of the spleen. Minimally enlarged spleens may not be felt under any circumstance. In one study, all spleens with an estimated weight (from scanning studies) exceeding 300 grams were palpable, with the average estimated weight of a palpable spleen being 285 grams [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/77\">",
"       77",
"      </a>",
"      ]. However, some spleens weighing as much as 900 grams are not palpable [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/78\">",
"       78",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The body habitus of the patient. The spleen is easier to feel in thin individuals and in those who do not have an increased anterior-posterior thoracic diameter.",
"     </li>",
"     <li>",
"      The skill of the examiner coupled with the ability of the patient to cooperate during the examination.",
"     </li>",
"     <li>",
"      The method(s) employed (see below).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Using ultrasound examination of the spleen as a gold standard (criteria described above), a number of studies have compared the various palpation and percussion techniques for evaluating splenic size. Major conclusions from all of these studies are the insensitivity of available techniques, wide interobserver variability, and the complementary value of combinations of techniques (ie, palpation plus percussion). Specific observations in individual studies can be summarized:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Palpation of the spleen was significantly more accurate in lean versus obese individuals [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/42\">",
"       42",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Sensitivity and specificity of percussion of Traube's semilunar space were 62 and 72 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/76\">",
"       76",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The specificity of direct splenic palpation was 92 percent, with a positive predictive value of 92 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/74\">",
"       74",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The combination of positive results on percussion of Traube's space (ie, dullness to percussion) and positive palpation had a sensitivity and specificity of 46 and 97 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If palpation maneuvers convince the examiner that the spleen is enlarged, this high degree of specificity suggests that follow-up scanning to confirm the finding is not necessary. However, scanning may still be useful to document baseline splenic involvement and size in preparation for treatment, or to document the presence of other abnormalities (eg, infiltrative disease of other abdominal organs, intraabdominal lymphadenopathy).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Splenic imaging for size estimation",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a reasonably close correlation between splenic weight and splenic size on external scanning. This was illustrated in a retrospective study of 81 patients who had undergone a total of 101 abdominal ultrasound examinations within four months of death and whose spleens were weighed during autopsy; the splenic weight in grams was equal to (0.43 x length x width x thickness) for measurements in centimeters [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of criteria have been proposed to define the size of the normal spleen in adults using these procedures:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ultrasound &mdash; The spleen is considered to be normal in size if its length is &lt;13 cm [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/72\">",
"       72",
"      </a>",
"      ] or its thickness is &le;5 cm on ultrasound examination [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/80\">",
"       80",
"      </a>",
"      ]. In one study of healthy stem cell donors, mean values for splenic length and width were 10.8 and 3.6 cm, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/81\">",
"       81",
"      </a>",
"      ]. The mean predictive errors for repeated ultrasound measurements of splenic length and width were 1.5 and 1.9 mm, respectively.",
"     </li>",
"     <li>",
"      Plain film &mdash; The spleen is normal in size if it is not seen on the abdominal plain film, if it is &lt;5 cm in width, or if it is less than 85 percent of the size of the normal kidney [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/77\">",
"       77",
"      </a>",
"      ]. It is considered enlarged if it is &gt;6 cm wide or &gt;13.6 cm long, or if (length x width) is &gt;75 cm2.",
"     </li>",
"     <li>",
"      Liver-spleen colloid scanning &mdash; The spleen is normal in size if its length on the posterior view of the liver-spleen scan is &le;13 cm [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/82\">",
"       82",
"      </a>",
"      ]. It is considered enlarged if the posterior length is &gt;14 cm, or if the lateral scan area exceeds 80 cm2 [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/77\">",
"       77",
"      </a>",
"      ]. In one study, 98 of 100 spleens with a posterior length &le;13 cm on colloid scanning weighed less than 250 grams and were normal at postmortem examination [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/82\">",
"       82",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      CT scanning &mdash; The spleen is enlarged if its length is &gt;10 cm [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/83\">",
"       83",
"      </a>",
"      ]. In one study this value had a sensitivity, specificity, and accuracy of 81, 90, and 88 percent, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A study of spleen size by CT scanning was done in adults 17 to 88 years of age to determine if a single measurement, as opposed to a volume determination, could be used to define splenomegaly [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/83\">",
"     83",
"    </a>",
"    ]. The authors evaluated splenic length, width, and thickness in 249 CT scans and assessed the spleen's relationship to the left lobe of the liver and the inferior third of the left kidney. Based upon an upper limit of 314 cubic cm for the volume of a normal spleen, they found a maximum normal spleen length of 9.8 cm, similar to be above-noted value of 10 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/83\">",
"     83",
"    </a>",
"    ]. If the spleen extended below the lower third of the kidney, this was also evidence for splenomegaly.",
"   </p>",
"   <p>",
"    Using the above criteria as \"gold standards\" for normal and abnormal splenic size, studies concerning the ability to palpate a normal or enlarged spleen have concluded that not all palpable spleens are abnormal; this is especially true in asthenic individuals. In one study, for example, no splenic pathology was clinically evident in 19 of 21 patients with palpable splenomegaly (at least two observers) and a posterior splenic length &le;13 cm on liver-spleen scan [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nevertheless, a palpable spleen",
"    <strong>",
"     usually",
"    </strong>",
"    means the presence of significant splenomegaly. As a general rule, a spleen has to be increased in size by at least 40 percent before it becomes palpable [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/84\">",
"     84",
"    </a>",
"    ]. However, it has been estimated that 20 percent of spleens with an estimated weight of more than 900 grams are not palpable [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2074335\">",
"    <span class=\"h3\">",
"     Splenic length in children",
"    </span>",
"    &nbsp;&mdash;&nbsp;In one study using ultrasound imaging, splenic lengths in hematologically normal children were as follows (values as mean [cm] &plusmn; 1 SD) [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/85\">",
"     85",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      5 to 6 years  8.4 &plusmn; 0.9",
"     </li>",
"     <li>",
"      7 to 8 years  8.5 &plusmn; 1.0",
"     </li>",
"     <li>",
"      9 to 10 years  8.6 &plusmn; 1.1",
"     </li>",
"     <li>",
"      11 to 12 years  9.7 &plusmn; 1.0",
"     </li>",
"     <li>",
"      13 to 14 years  10.1 &plusmn; 1.2",
"     </li>",
"     <li>",
"      15 to 16 years  10.1 &plusmn; 1.0",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     CAUSES OF SPLENOMEGALY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     General conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of an enlarged spleen are multiple; most reflect the presence of hepatic or hematologic disease, infection, or inflammation (",
"    <a class=\"graphic graphic_table graphicRef69397 \" href=\"UTD.htm?26/43/27324\">",
"     table 2",
"    </a>",
"    ). Such causes include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Splenic engorgement due to sequestration of red blood cells, as in congenital spherocytosis or other congenital or acquired hemolytic anemias. A significantly enlarged spleen is routinely seen in normal subjects serving as hematopoietic cell donors following treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/13/23767?source=see_link\">",
"       granulocyte colony-stimulating factor",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/81,86\">",
"       81,86",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Other causes for splenic engorgement include splenic trauma with intracapsular hematoma formation, sequestration crisis in sickle cell disease, chronic congestive failure, or portal hypertension. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/57/3993?source=see_link&amp;anchor=H6#H6\">",
"       \"Extrahepatic portal vein obstruction (portal vein thrombosis)\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chronic inflammation or infection, as in systemic lupus erythematosus, rheumatoid arthritis, infective endocarditis, or chronic malaria. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4247?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical manifestations and diagnosis of Felty's syndrome\", section on 'Splenomegaly'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lipid deposition disorders such as Gaucher disease (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/11/9402?source=see_link\">",
"       \"Gaucher disease: Pathogenesis, clinical manifestations, and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Congenital causes for splenomegaly include splenic hemangioma, hamartoma, or cysts.",
"     </li>",
"     <li>",
"      Splenic invasion with granulomatous or malignant hematologic disease.",
"     </li>",
"     <li>",
"      Primary vascular neoplasms (eg, angiosarcoma) [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/87\">",
"       87",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Splenic metastases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Non-hematologic malignancies rarely metastasize to the spleen. The most common primary sites include breast, lung, colorectal, ovarian carcinomas and melanoma in cases of cancer involving multiple visceral sites and colorectal and ovarian carcinomas in cases in which there is a solitary splenic lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/88\">",
"     88",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Common causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relative frequency of the different causes of splenomegaly was evaluated in a series of 449 patients who were studied retrospectively and categorized; the most common cause in each category is shown in parentheses [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/89\">",
"     89",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Liver disease &mdash; 33 percent (cirrhosis)",
"     </li>",
"     <li>",
"      Hematologic malignancy &mdash; 27 percent (lymphoma)",
"     </li>",
"     <li>",
"      Infection &mdash; 23 percent (AIDS, endocarditis)",
"     </li>",
"     <li>",
"      Congestion or inflammation &mdash; 8 percent (congestive failure)",
"     </li>",
"     <li>",
"      Primary splenic disease &mdash; 4 percent (splenic vein thrombosis)",
"     </li>",
"     <li>",
"      Other or unknown &mdash; 5 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Massively enlarged spleen",
"    </span>",
"    &nbsp;&mdash;&nbsp;A spleen enlarged such that its lower pole is within the pelvis, or which has crossed the midline into the right lower or right upper abdominal quadrants is considered to be massively enlarged. There are only a few conditions that cause this degree of splenic enlargement, each of which discussed elsewhere on the appropriate topic reviews:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chronic myeloid leukemia",
"     </li>",
"     <li>",
"      Myelofibrosis, primary or secondary to polycythemia vera or essential thrombocytosis",
"     </li>",
"     <li>",
"      Gaucher disease",
"     </li>",
"     <li>",
"      Lymphoma, usually indolent, including hairy cell leukemia [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/90\">",
"       90",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Kala-azar (visceral leishmaniasis)",
"     </li>",
"     <li>",
"      Hyperreactive malarial splenomegaly syndrome, also called tropical splenomegaly syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/91\">",
"       91",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Beta thalassemia major",
"     </li>",
"     <li>",
"      AIDS with Mycobacterium avium complex [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/89\">",
"       89",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     EVALUATION OF THE PATIENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Initial approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history may provide valuable clues as to the cause of splenomegaly. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A patient with chronic alcoholism or hepatitis and ascites probably has splenomegaly secondary to cirrhosis and portal hypertension. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23194?source=see_link\">",
"       \"Diagnostic approach to the patient with cirrhosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A young adult with fatigue, fever, sore throat, and splenomegaly is likely to have infectious mononucleosis or other viral infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=see_link&amp;anchor=H6#H6\">",
"       \"Infectious mononucleosis in adults and adolescents\", section on 'Classic IM'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An older adult complaining of post-bath pruritus with a ruddy complexion and splenomegaly is likely to have polycythemia vera. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9738?source=see_link\">",
"       \"Diagnostic approach to the patient with suspected polycythemia vera\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the patient with systemic complaints such as fever, night sweats, malaise,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    weight loss, an enlarged spleen may reflect activity of a systemic disease that may have already been diagnosed, such as AIDS, systemic lupus erythematosus, rheumatoid arthritis, sarcoidosis, malaria, tuberculosis, viral infection (infectious mononucleosis, cytomegalovirus, hepatitis), or hematologic disorders (chronic myeloid leukemia, chronic lymphocytic leukemia, hairy cell leukemia). In such cases, the spleen may revert to normal size when the underlying disease is brought under control with appropriate therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2090784\">",
"    <span class=\"h3\">",
"     Unexplained splenomegaly",
"    </span>",
"    &nbsp;&mdash;&nbsp;A problem often confronting the examining clinician is when the patient presents with splenomegaly for which no prior diagnosed or evident condition can be considered responsible. A reasonable and standard approach to such patients begins with an accurate history (including recent travel information), physical examination, complete blood count with white blood cell differential and platelet count and examination of the peripheral blood smear, liver function studies, urinalysis, and chest x-ray. Testing for the presence of antibodies to HIV should be considered when no other causes for splenomegaly are apparent. Abnormalities found at this time should help guide the physician to an appropriate diagnosis. (See",
"    <a class=\"local\" href=\"#H31\">",
"     'Additional approaches'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of imaging techniques are available for assessment of splenic lesions (eg, splenic cysts, other space- occupying lesions), including CT scanning, magnetic resonance imaging, ultrasound, Tc-99m sulfur colloid scintigraphy, and 18F-FDG PET. The age of the patient, clinical symptomatology, and imaging characteristics may help the radiologist arrive at the correct diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/59,92-94\">",
"     59,92-94",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     CBC and peripheral smear",
"    </span>",
"    &nbsp;&mdash;&nbsp;The complete blood count, examination of the peripheral smear, and white blood cell differential are often of utmost importance in determining the cause of an enlarged spleen:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neutropenia, anemia,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      thrombocytopenia may be present, as these formed elements can be trapped in an enlarged spleen, giving the nonspecific picture termed \"hypersplenism.\" (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/62/9194?source=see_link&amp;anchor=H28#H28\">",
"       \"Extrinsic nonimmune hemolytic anemia due to mechanical damage: Fragmentation hemolysis and hypersplenism\", section on 'Extravascular nonimmune hemolysis due to hypersplenism'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      There is no predictable relationship between the degree of splenomegaly and the presence or degree of these cytopenias or of possible associated symptoms such as colicky abdominal or left upper quadrant pain, pain while lying on one's side, or early satiety [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/4\">",
"       4",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The cytopenias seen with hypersplenism are not associated with abnormal white blood cell or red blood cell forms. However, cytopenias are nonspecific, as multiple other causes, including certain infections, can provoke these changes in a patient with splenomegaly.",
"     </li>",
"     <li>",
"      Neutrophilia (ie, absolute neutrophil count",
"      <span class=\"nowrap\">",
"       &gt;7700/microL)",
"      </span>",
"      with or without increased numbers of band and metamyelocyte forms (\"left shift\"), suggest the presence of infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29511?source=see_link\">",
"       \"Approach to the patient with neutrophilia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      On occasion, invading organisms may be seen on the peripheral smear, either free in the plasma as in overwhelming sepsis, or within neutrophils or monocytes (bacteria, ehrlichiae) or red blood cells as occurs with bartonellosis, babesiosis (",
"      <a class=\"graphic graphic_picture graphicRef56898 \" href=\"UTD.htm?24/56/25478\">",
"       picture 3",
"      </a>",
"      ), and malaria (",
"      <a class=\"graphic graphic_picture graphicRef59872 graphicRef78176 \" href=\"UTD.htm?35/11/36019\">",
"       picture 4A-B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/34/6697?source=see_link&amp;anchor=H6#H6\">",
"       \"Extrinsic nonimmune hemolytic anemia due to systemic disease\", section on 'Direct parasitization'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with overwhelming bacterial sepsis may show other abnormalities on smear, including microangiopathic changes in red blood cells (",
"      <a class=\"graphic graphic_picture graphicRef70851 \" href=\"UTD.htm?37/50/38694\">",
"       picture 5",
"      </a>",
"      ) and toxic granulation, vacuoles, and Dohle bodies in neutrophils (",
"      <a class=\"graphic graphic_picture graphicRef70248 \" href=\"UTD.htm?7/17/7449\">",
"       picture 6",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29511?source=see_link&amp;anchor=H11#H11\">",
"       \"Approach to the patient with neutrophilia\", section on 'Evaluation of the complete blood count'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Certain infectious organisms are associated with relatively specific changes, such as red blood cell agglutination due to the presence of cold agglutinins (",
"      <a class=\"graphic graphic_picture graphicRef50522 \" href=\"UTD.htm?15/10/15527\">",
"       picture 7",
"      </a>",
"      ) in infections with Mycoplasma pneumoniae or in infectious mononucleosis, and the atypical lymphocytes seen in the latter infection (",
"      <a class=\"graphic graphic_picture graphicRef55986 \" href=\"UTD.htm?1/24/1410\">",
"       picture 8",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30535?source=see_link\">",
"       \"Pathogenesis of autoimmune hemolytic anemia: Cold agglutinin disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=see_link\">",
"       \"Infectious mononucleosis in adults and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The combination of sepsis and profound anemia along with hemoglobinemia, hemoglobinuria, and the presence of microspherocytes and red cell ghosts on the peripheral blood smear (ie, massive intravascular hemolysis) suggests infection with a phospholipase-producing Clostridial organism. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/62/12264?source=see_link&amp;anchor=H6#H6\">",
"       \"Clostridial myonecrosis\", section on 'Clinical manifestations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/34/6697?source=see_link&amp;anchor=H12#H12\">",
"       \"Extrinsic nonimmune hemolytic anemia due to systemic disease\", section on 'Clostridium perfringens'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The presence of white blood cells less mature than band forms and nucleated red cells on the peripheral smear, along with teardrop-shaped red cells (ie, a leukoerythroblastic blood picture) (",
"      <a class=\"graphic graphic_picture graphicRef68110 \" href=\"UTD.htm?29/43/30390\">",
"       picture 9",
"      </a>",
"      ), suggests the presence of widespread bone marrow invasion with malignancy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38213?source=see_link&amp;anchor=H12#H12\">",
"       \"Anemias due to decreased red cell production\", section on 'Leukoerythroblastic anemia'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      This picture may also be seen in tuberculosis and chronic myeloid leukemia and is quite typical for primary and secondary forms of myelofibrosis. These three diagnoses can be established through culture and staining techniques, the presence of the bcr-abl construct or Ph1 chromosome, and bone marrow biopsy, respectively.",
"     </li>",
"     <li>",
"      Patients with neutropenia and rheumatoid arthritis may have an increased percentage of circulating large granular lymphocytes (",
"      <a class=\"graphic graphic_picture graphicRef69027 \" href=\"UTD.htm?0/1/28\">",
"       picture 10",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/62/5095?source=see_link\">",
"       \"Large granular lymphocyte leukemia in rheumatoid arthritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The presence of increased numbers of abnormal cells in the peripheral blood suggests the presence of a hematologic malignancy. Morphologic evaluation, coupled with special staining and immunocytochemical techniques, can help to establish the correct diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/95\">",
"       95",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38313?source=see_link&amp;anchor=H34#H34\">",
"       \"Evaluation of the peripheral blood smear\", section on 'Worrisome findings'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Additional approaches",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5011755\">",
"    <span class=\"h3\">",
"     General considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;If no abnormalities are suggested by the above workup, CT examination of the chest and abdomen should be performed to evaluate the patient for disseminated or intra-abdominal malignancy, such as hepatoma or lymphoma, advanced liver disease, or portal hypertension. Consultation with a hematologist would be appropriate at this time, especially if examination of the peripheral blood smear has not been performed, or if changes are present which cannot be adequately assessed by the patient's primary clinician.",
"   </p>",
"   <p>",
"    An alternative approach is to biopsy tissue depending upon the clinical suspicion. Thus, if infection is suspected, a lymph node or bone marrow aspiration and biopsy may be indicated, a liver biopsy if liver disease is suspected, and a bone marrow biopsy if a hematologic disorder is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/89\">",
"     89",
"    </a>",
"    ]. Without a specific organ or tissue to biopsy, a reasonable approach would be performance of a bone marrow aspiration with biopsy with culture. Conditions such as lipid storage diseases, disseminated mycobacterial or granulomatous disease, and lymphoid or myeloid disorders may be diagnosed in this way (",
"    <a class=\"graphic graphic_picture graphicRef75651 \" href=\"UTD.htm?16/63/17398\">",
"     picture 11",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef59255 \" href=\"UTD.htm?14/18/14630\">",
"     picture 12",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/11/9402?source=see_link\">",
"     \"Gaucher disease: Pathogenesis, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Diagnostic splenectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the above procedures have not led to a diagnosis (eg, abdominal sonography, whole body CT examination, bone marrow aspiration and biopsy, examination of the peripheral smear, tests of liver and kidney function [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/96\">",
"     96",
"    </a>",
"    ]), splenectomy may be considered, with the value of making a diagnosis balanced by considerations not only of surgical morbidity and mortality, but also of disease-specific complications of splenectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/1/20506?source=see_link&amp;anchor=H10#H10\">",
"     \"Hereditary spherocytosis: Clinical features; diagnosis; and treatment\", section on 'Splenectomy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"./treatment-and-prognosis-of-immune-thrombocytopenia-itp-in-adults?source=see_link&amp;anchor=H17#H17\">",
"     \"Treatment and prognosis of immune thrombocytopenia (ITP) in adults\", section on 'Splenectomy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36922?source=see_link&amp;anchor=H15#H15\">",
"     \"Prognosis and treatment of primary myelofibrosis\", section on 'Splenectomy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/39/7802?source=see_link&amp;anchor=H18#H18\">",
"     \"Treatment of beta thalassemia\", section on 'Splenectomy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/63/6138?source=see_link&amp;anchor=H24#H24\">",
"     \"Clinical aspects, diagnosis, and treatment of the sideroblastic anemias\", section on 'Risk of splenectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The resected spleen may reveal a localized splenic tumor, cyst(s), inflammatory pseudotumor, hamartoma, amyloid, vascular anomaly, infection, sarcoidosis, or other rare condition [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/97,98\">",
"     97,98",
"    </a>",
"    ]. In some cases, a satisfactory answer may not be available even after pathologic examination. In a series of 122 \"diagnostic\" splenectomies performed for unexplained splenomegaly, splenic mass lesion, or to accurately classify a lymphoproliferative disorder detected but not further characterizable on bone marrow or peripheral blood examination, the most common pathologic diagnoses were [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/99\">",
"     99",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       Lymphoma/leukemia",
"      </span>",
"      &mdash; 57 percent",
"     </li>",
"     <li>",
"      Metastatic",
"      <span class=\"nowrap\">",
"       carcinoma/sarcoma",
"      </span>",
"      &mdash; 11 percent",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Cyst/pseudocyst",
"      </span>",
"      &mdash; 9 percent",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Benign/malignant",
"      </span>",
"      vascular neoplasm &mdash; 7 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the subgroup of 41 patients undergoing splenectomy for splenomegaly without a splenic mass lesion or evidence of a lymphoproliferative disorder,",
"    <span class=\"nowrap\">",
"     lymphoma/leukemia",
"    </span>",
"    was still the most common pathologic diagnosis (58 percent). Of interest, no distinct histologic abnormality was found in 5 percent of the 122 resected spleens. Similar results were reported in two series of patients undergoing diagnostic splenectomy, in which a lymphoma was found in 37 and 39 percent of the resected spleens [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/100,101\">",
"     100,101",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5011770\">",
"    <span class=\"h3\">",
"     Splenic aspiration/biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Splenic",
"    <span class=\"nowrap\">",
"     aspiration/biopsy",
"    </span>",
"    is not widely practiced in the United States because of the risk of bleeding. As an example, a 1985 study reported a major complication rate of 13 percent for percutaneous biopsy of the spleen performed with a 14 gauge needle [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/102\">",
"     102",
"    </a>",
"    ]. However, subsequent reports of fine needle",
"    <span class=\"nowrap\">",
"     aspiration/biopsy",
"    </span>",
"    of the spleen under radiologic or ultrasound guidance have indicated much lower complication rates using smaller diameter needles (ie, 18 gauge or smaller), allowing for a safer procedure along with avoidance of the need for major surgical intervention (ie, open splenic biopsy or splenectomy) [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/103-107\">",
"     103-107",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a meta-analysis that included four studies meeting inclusion criteria for diagnostic accuracy (639 patients) and nine studies meeting inclusion criteria for complication rates (741 patients), it was concluded that image-guided percutaneous biopsy of the spleen demonstrated high diagnostic accuracy, with a sensitivity and specificity of 87 and 96 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?33/34/34346/abstract/108\">",
"     108",
"    </a>",
"    ]. The pooled overall complication rate was 4.2 percent (core needle biopsy: 5.8 percent, fine needle aspiration biopsy: 4.3 percent). However, sensitivity analysis with the removal of biopsies performed with needles larger than 18 gauge showed overall and major complication rates of 3.9 and 1.3 percent, respectively, similar to those reported for biopsies of the liver and kidney.",
"   </p>",
"   <p>",
"    While splenic",
"    <span class=\"nowrap\">",
"     aspiration/biopsy",
"    </span>",
"    is safer than it was in the past, we believe that this procedure is of minimal clinical utility and does not provide information that could not be obtained by other means.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14392127\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14392135\">",
"    <span class=\"h2\">",
"     Splenic function",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spleen has the following major functions. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H3\">",
"     'Normal splenic function'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Participates in cellular and humoral immunity",
"     </li>",
"     <li>",
"      Removes senescent",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      poorly deformable red cells, bacteria, and other particulates from the circulation",
"     </li>",
"     <li>",
"      Under abnormal circumstances the spleen may become the site of extramedullary hematopoiesis",
"     </li>",
"     <li>",
"      Approximately one-third of circulating platelets are sequestered in the spleen, where they are in equilibrium with circulating platelets",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14392321\">",
"    <span class=\"h2\">",
"     Normal splenic size",
"    </span>",
"    &nbsp;&mdash;&nbsp;The median splenic weight in adults is about 150 grams and the organ is not usually palpable on physical examination. In one study the average estimated weight of a palpable spleen was 285 grams. On ultrasound the spleen is considered to be normal in size if its length is &lt;13 cm. (See",
"    <a class=\"local\" href=\"#H2090715\">",
"     'Splenic size and palpability'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14392193\">",
"    <span class=\"h2\">",
"     Splenic abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of an enlarged or abnormal spleen include one or all of the following. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Symptoms'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pain, fullness, or discomfort in the left upper quadrant of the abdomen",
"     </li>",
"     <li>",
"      Pain referred to the left shoulder",
"     </li>",
"     <li>",
"      Early fullness after meals, due to pressure on the adjacent stomach",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Splenic abnormalities can include the following. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Splenic disorders'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased function (hypersplenism). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Hypersplenism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Decreased to absent function (hyposplenism, asplenia). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Hyposplenism and asplenia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Abscess, infarction, calcification, cysts. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Splenic abscess'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Splenic infarction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Splenic calcification and cysts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Traumatic or atraumatic rupture. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Splenic rupture'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14392344\">",
"    <span class=\"h2\">",
"     Causes for an enlarged spleen",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major causes for an enlarged spleen are shown in the table (",
"    <a class=\"graphic graphic_table graphicRef69397 \" href=\"UTD.htm?26/43/27324\">",
"     table 2",
"    </a>",
"    ). Only a few disorders are associated with a massively enlarged spleen (ie, lower pole within the pelvis or the splenic edge has crossed the midline). (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Causes of splenomegaly'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H26\">",
"     'Massively enlarged spleen'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/1\">",
"      Wilkins BS. The spleen. Br J Haematol 2002; 117:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/2\">",
"      Rodeghiero F, Ruggeri M. Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications? Br J Haematol 2012; 158:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/3\">",
"      Crary SE, Buchanan GR. Vascular complications after splenectomy for hematologic disorders. Blood 2009; 114:2861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/4\">",
"      Gielchinsky Y, Elstein D, Hadas-Halpern I, et al. Is there a correlation between degree of splenomegaly, symptoms and hypersplenism? A study of 218 patients with Gaucher disease. Br J Haematol 1999; 106:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/5\">",
"      Buffet PA, Milon G, Brousse V, et al. Ex vivo perfusion of human spleens maintains clearing and processing functions. Blood 2006; 107:3745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/6\">",
"      Logan A, Berube C, Gotlib J. Accessory splenules in autoimmune hemolytic anemia. Am J Hematol 2013; 88:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/7\">",
"      Bernaudin F, Socie G, Kuentz M, et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007; 110:2749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/8\">",
"      Pearson HA, Cornelius EA, Schwartz AD, et al. Transfusion-reversible functional asplenia in young children with sickle-cell anemia. N Engl J Med 1970; 283:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/9\">",
"      Wethers DL, Grover R. Reversibility of splenic function by transfusion in two young adults with sickle cell anemia. Am J Pediatr Hematol Oncol 1987; 9:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/10\">",
"      Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of \"hypersplenic\" thrombocytopenia. J Clin Invest 1966; 45:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/11\">",
"      Santos A, Pinheiro V, Anjos C, et al. Scintigraphic follow-up of the effects of therapy with hydroxyurea on splenic function in patients with sickle cell disease. Eur J Nucl Med Mol Imaging 2002; 29:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/12\">",
"      Powsner RA, Simms RW, Chudnovsky A, et al. Scintigraphic functional hyposplenism in amyloidosis. J Nucl Med 1998; 39:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/13\">",
"      Y&uuml;cel AE, Durak H, Bernay I, et al. Functional asplenia and portal hypertension in a patient with primary splenic hemangiosarcoma. Clin Nucl Med 1990; 15:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/14\">",
"      Fishman D, Isenberg DA. Splenic involvement in rheumatic diseases. Semin Arthritis Rheum 1997; 27:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/15\">",
"      Piliero P, Furie R. Functional asplenia in systemic lupus erythematosus. Semin Arthritis Rheum 1990; 20:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/16\">",
"      Muller AF, Cornford E, Toghill PJ. Splenic function in inflammatory bowel disease: assessment by differential interference microscopy and splenic ultrasound. Q J Med 1993; 86:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/17\">",
"      Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet 2011; 378:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/18\">",
"      Rogers ZR, Wang WC, Luo Z, et al. Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial. Blood 2011; 117:2614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/19\">",
"      Lammers AJ, de Porto AP, Bennink RJ, et al. Hyposplenism: comparison of different methods for determining splenic function. Am J Hematol 2012; 87:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/20\">",
"      Prendki V, Ndour PA, Jais X, et al. Reduced deformability of circulating erythrocytes: a marker of hyposplenism. Am J Hematol 2012; 87:E81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/21\">",
"      Harrod VL, Howard TA, Zimmerman SA, et al. Quantitative analysis of Howell-Jolly bodies in children with sickle cell disease. Exp Hematol 2007; 35:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/22\">",
"      Corazza GR, Ginaldi L, Zoli G, et al. Howell-Jolly body counting as a measure of splenic function. A reassessment. Clin Lab Haematol 1990; 12:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/23\">",
"      Corazza GR, Tarozzi C, Vaira D, et al. Return of splenic function after splenectomy: how much tissue is needed? Br Med J (Clin Res Ed) 1984; 289:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/24\">",
"      Brancatelli G, Vilgrain V, Zappa M, Lagalla R. Case 80: splenosis. Radiology 2005; 234:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/25\">",
"      Kiser JW, Fagien M, Clore FF. Splenosis mimicking a left renal mass. AJR Am J Roentgenol 1996; 167:1508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/26\">",
"      Lake ST, Johnson PT, Kawamoto S, et al. CT of splenosis: patterns and pitfalls. AJR Am J Roentgenol 2012; 199:W686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/27\">",
"      White CS, Meyer CA. General case of the day. Thoracic splenosis. Radiographics 1998; 18:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/28\">",
"      Khosravi MR, Margulies DR, Alsabeh R, et al. Consider the diagnosis of splenosis for soft tissue masses long after any splenic injury. Am Surg 2004; 70:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/29\">",
"      Backhus LM, Bremner RM. Images in clinical medicine. Intrathoracic splenosis after remote trauma. N Engl J Med 2006; 355:1811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/30\">",
"      Massey MD, Stevens JS. Residual spleen found on denatured red blood cell scan following negative colloid scans. J Nucl Med 1991; 32:2286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/31\">",
"      Fremont RD, Rice TW. Splenosis: a review. South Med J 2007; 100:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/32\">",
"      Ting W, Silverman NA, Arzouman DA, Levitsky S. Splenic septic emboli in endocarditis. Circulation 1990; 82:IV105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/33\">",
"      Robinson SL, Saxe JM, Lucas CE, et al. Splenic abscess associated with endocarditis. Surgery 1992; 112:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/34\">",
"      Johnson JD, Raff MJ, Barnwell PA, Chun CH. Splenic abscess complicating infectious endocarditis. Arch Intern Med 1983; 143:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/35\">",
"      Brook I, Frazier EH. Microbiology of liver and spleen abscesses. J Med Microbiol 1998; 47:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/36\">",
"      Lee CH, Leu HS, Hu TH, Liu JW. Splenic abscess in southern Taiwan. J Microbiol Immunol Infect 2004; 37:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/37\">",
"      Ebright JR, Alam E, Ahmed H, et al. Splenic infarction and abscess in the setting of infective endocarditis. Infect Dis Clin Pract 2007; 15:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/38\">",
"      Lawrence YR, Pokroy R, Berlowitz D, et al. Splenic infarction: an update on William Osler's observations. Isr Med Assoc J 2010; 12:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/39\">",
"      Nores M, Phillips EH, Morgenstern L, Hiatt JR. The clinical spectrum of splenic infarction. Am Surg 1998; 64:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/40\">",
"      G&ouml;rg C, Seifart U, G&ouml;rg K. Acute, complete splenic infarction in cancer patient is associated with a fatal outcome. Abdom Imaging 2004; 29:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/41\">",
"      Beeson MS. Splenic infarct presenting as acute abdominal pain in an older patient. J Emerg Med 1996; 14:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/42\">",
"      Barkun AN, Camus M, Green L, et al. The bedside assessment of splenic enlargement. Am J Med 1991; 91:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/43\">",
"      Haan JM, Bochicchio GV, Kramer N, Scalea TM. Nonoperative management of blunt splenic injury: a 5-year experience. J Trauma 2005; 58:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/44\">",
"      Franklin QJ, Compeggie M. Splenic syndrome in sickle cell trait: four case presentations and a review of the literature. Mil Med 1999; 164:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/45\">",
"      Jama AH, Salem AH, Dabbous IA. Massive splenic infarction in Saudi patients with sickle cell anemia: a unique manifestation. Am J Hematol 2002; 69:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/46\">",
"      Al-Salem AH, Naserullah Z, Qaisaruddin S, et al. Splenic complications of the sickling syndromes and the role of splenectomy. J Pediatr Hematol Oncol 1999; 21:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/47\">",
"      Dasanu CA, Codreanu I. Images in clinical medicine. Splenic calcification. N Engl J Med 2011; 365:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/48\">",
"      Liu Y, Wang X, Wu J. Continuous long-term albendazole therapy in intraabdominal cystic echinococcosis. Chin Med J (Engl) 2000; 113:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/49\">",
"      Abbas MA, Stone WM, Fowl RJ, et al. Splenic artery aneurysms: two decades experience at Mayo clinic. Ann Vasc Surg 2002; 16:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/50\">",
"      Yamazaki K. A case of splenic lymphoma with marked diffuse nodular fibrosis and calcification, complicated with severe autoimmune hemolytic anemia. J Submicrosc Cytol Pathol 2003; 35:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/51\">",
"      Ruiz Carazo E, Mu&ntilde;oz Parra F, Jim&eacute;nez Villares MP, et al. Hepatosplenic brucelloma: clinical presentation and imaging features in six cases. Abdom Imaging 2005; 30:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/52\">",
"      Wan YL, Cheung YC, Lui KW, et al. Ultrasonographic findings and differentiation of benign and malignant focal splenic lesions. Postgrad Med J 2000; 76:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/53\">",
"      Ha HK, Jung JI, Lee MS, et al. CT differentiation of tuberculous peritonitis and peritoneal carcinomatosis. AJR Am J Roentgenol 1996; 167:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/54\">",
"      Kinoshita T, Ishii K, Yajima Y, et al. Splenic hemangiosarcoma with massive calcification. Abdom Imaging 1999; 24:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/55\">",
"      Ros PR, Moser RP Jr, Dachman AH, et al. Hemangioma of the spleen: radiologic-pathologic correlation in ten cases. Radiology 1987; 162:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/56\">",
"      Fyfe AJ, Gallipoli P. Multiple splenic calcifications. Br J Haematol 2009; 144:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/57\">",
"      Sagoh T, Itoh K, Togashi K, et al. Gamna-Gandy bodies of the spleen: evaluation with MR imaging. Radiology 1989; 172:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/58\">",
"      Hansen MB, Moller AC. Splenic cysts. Surg Laparosc Endosc Percutan Tech 2004; 14:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/59\">",
"      Warshauer DM, Hall HL. Solitary splenic lesions. Semin Ultrasound CT MR 2006; 27:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/60\">",
"      Gianom D, Wildisen A, Hotz T, et al. Open and laparoscopic treatment of nonparasitic splenic cysts. Dig Surg 2003; 20:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/61\">",
"      Chin EH, Shapiro R, Hazzan D, et al. A ten-year experience with laparoscopic treatment of splenic cysts. JSLS 2007; 11:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/62\">",
"      Mertens J, Penninckx F, DeWever I, Topal B. Long-term outcome after surgical treatment of nonparasitic splenic cysts. Surg Endosc 2007; 21:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/63\">",
"      Renzulli P, Hostettler A, Schoepfer AM, et al. Systematic review of atraumatic splenic rupture. Br J Surg 2009; 96:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/64\">",
"      olovi R, olovi N, Grubor N, Kaitovi M. [Symptomatic calcified splenic artery aneurysm: case report]. Srp Arh Celok Lek 2010; 138:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/65\">",
"      Rahmoune FC, Aya G, Biard M, et al. [Splenic artery aneurysm rupture in late pregnancy: a case report and review of the literature]. Ann Fr Anesth Reanim 2011; 30:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/66\">",
"      Saba L, Anzidei M, Lucatelli P, Mallarini G. The multidetector computed tomography angiography (MDCTA) in the diagnosis of splenic artery aneurysm and pseudoaneurysm. Acta Radiol 2011; 52:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/67\">",
"      Lakin RO, Bena JF, Sarac TP, et al. The contemporary management of splenic artery aneurysms. J Vasc Surg 2011; 53:958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/68\">",
"      Giulianotti PC, Buchs NC, Coratti A, et al. Robot-assisted treatment of splenic artery aneurysms. Ann Vasc Surg 2011; 25:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/69\">",
"      Maillard M, Novellas S, Baudin G, et al. [Splenic artery aneurysm: diagnosis and endovascular therapy]. J Radiol 2010; 91:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/70\">",
"      Picardi M, Martinelli V, Ciancia R, et al. Measurement of spleen volume by ultrasound scanning in patients with thrombocytosis: a prospective study. Blood 2002; 99:4228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/71\">",
"      McIntyre OR, Ebaugh FG Jr. Palpable spleens in college freshmen. Ann Intern Med 1967; 66:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/72\">",
"      Tamayo SG, Rickman LS, Mathews WC, et al. Examiner dependence on physical diagnostic tests for the detection of splenomegaly: a prospective study with multiple observers. J Gen Intern Med 1993; 8:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/73\">",
"      Yang JC, Rickman LS, Bosser SK. The clinical diagnosis of splenomegaly. West J Med 1991; 155:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/74\">",
"      Chongtham DS, Singh MM, Kalantri SP, Pathak S. Accuracy of palpation and percussion manoeuvres in the diagnosis of splenomegaly. Indian J Med Sci 1997; 51:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/75\">",
"      Verghese A, Krish G, Karnad A. Ludwig Traube. The man and his space. Arch Intern Med 1992; 152:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/76\">",
"      Barkun AN, Camus M, Meagher T, et al. Splenic enlargement and Traube's space: how useful is percussion? Am J Med 1989; 87:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/77\">",
"      Aito H. The estimation of the size of the spleen by radiological methods. A comparative radiographic, gamma imaging and ultrasonic study. Ann Clin Res 1974; 6 Suppl 15:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/78\">",
"      Silverman S, DeNardo Gl, Glatstein E, Lipton MJ. Evaluation of the liver and spleen in Hodgkin's disease. II. The value of splenic scintigraphy. Am J Med 1972; 52:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/79\">",
"      Downey MT. Estimation of splenic weight from ultrasonographic measurements. Can Assoc Radiol J 1992; 43:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/80\">",
"      Doll M, Sch&ouml;lmerich J, Spamer C, et al. [Clinical significance of sonographically detected splenomegaly]. Dtsch Med Wochenschr 1986; 111:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/81\">",
"      Platzbecker U, Prange-Krex G, Bornh&auml;user M, et al. Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion 2001; 41:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/82\">",
"      Arkles LB, Gill GD, Molan MP. A palpable spleen is not necessarily enlarged or pathological. Med J Aust 1986; 145:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/83\">",
"      Bezerra AS, D'Ippolito G, Faintuch S, et al. Determination of splenomegaly by CT: is there a place for a single measurement? AJR Am J Roentgenol 2005; 184:1510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/84\">",
"      BLACKBURN CR. On the clinical detection of enlargement of the spleen. Australas Ann Med 1953; 2:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/85\">",
"      Dittrich M, Milde S, Dinkel E, et al. Sonographic biometry of liver and spleen size in childhood. Pediatr Radiol 1983; 13:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/86\">",
"      Stroncek D, Shawker T, Follmann D, Leitman SF. G-CSF-induced spleen size changes in peripheral blood progenitor cell donors. Transfusion 2003; 43:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/87\">",
"      Chun YS, Robu VG. Spectrum of primary vascular neoplasms of the spleen. J Clin Oncol 2011; 29:e116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/88\">",
"      Comp&eacute;rat E, Bardier-Dupas A, Camparo P, et al. Splenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesis. Arch Pathol Lab Med 2007; 131:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/89\">",
"      O'Reilly RA. Splenomegaly in 2,505 patients at a large university medical center from 1913 to 1995. 1963 to 1995: 449 patients. West J Med 1998; 169:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/90\">",
"      Monterroso J, Chandana S. Images in clinical medicine. Massive splenomegaly in hairy-cell leukemia. N Engl J Med 2012; 367:2133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/91\">",
"      Bedu-Addo G, Bates I. Causes of massive tropical splenomegaly in Ghana. Lancet 2002; 360:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/92\">",
"      Kamaya A, Weinstein S, Desser TS. Multiple lesions of the spleen: differential diagnosis of cystic and solid lesions. Semin Ultrasound CT MR 2006; 27:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/93\">",
"      Paterson A, Frush DP, Donnelly LF, et al. A pattern-oriented approach to splenic imaging in infants and children. Radiographics 1999; 19:1465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/94\">",
"      Metser U, Even-Sapir E. The role of 18F-FDG PET/CT in the evaluation of solid splenic masses. Semin Ultrasound CT MR 2006; 27:420.",
"     </a>",
"    </li>",
"    <li>",
"     Harris NL III. The patient with splenomegaly and lymphocytosis: A diagnostic dilemma. In: Hematology 1998: The American Society of Hematology education program book. p.99.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/96\">",
"      Iannitto E, Tripodo C. How I diagnose and treat splenic lymphomas. Blood 2011; 117:2585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/97\">",
"      Makrin V, Avital S, White I, et al. Laparoscopic splenectomy for solitary splenic tumors. Surg Endosc 2008; 22:2009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/98\">",
"      Shapiro AJ, Adams ED. Inflammatory pseudotumor of the spleen managed laparoscopically. Can preoperative imaging establish the diagnosis? Case report and literature review. Surg Laparosc Endosc Percutan Tech 2006; 16:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/99\">",
"      Kraus MD, Fleming MD, Vonderheide RH. The spleen as a diagnostic specimen: a review of 10 years' experience at two tertiary care institutions. Cancer 2001; 91:2001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/100\">",
"      Carr JA, Shurafa M, Velanovich V. Surgical indications in idiopathic splenomegaly. Arch Surg 2002; 137:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/101\">",
"      Pottakkat B, Kashyap R, Kumar A, et al. Redefining the role of splenectomy in patients with idiopathic splenomegaly. ANZ J Surg 2006; 76:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/102\">",
"      Lindgren PG, Hagberg H, Eriksson B, et al. Excision biopsy of the spleen by ultrasonic guidance. Br J Radiol 1985; 58:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/103\">",
"      Silverman JF, Geisinger KR, Raab SS, Stanley MW. Fine needle aspiration biopsy of the spleen in the evaluation of neoplastic disorders. Acta Cytol 1993; 37:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/104\">",
"      Moriarty AT, Schwenk GR Jr, Chua G. Splenic fine needle aspiration biopsy in the diagnosis of lymphoreticular diseases. A report of four cases. Acta Cytol 1993; 37:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/105\">",
"      Civardi G, Vallisa D, Bert&egrave; R, et al. Ultrasound-guided fine needle biopsy of the spleen: high clinical efficacy and low risk in a multicenter Italian study. Am J Hematol 2001; 67:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/106\">",
"      Lieberman S, Libson E, Maly B, et al. Imaging-guided percutaneous splenic biopsy using a 20- or 22-gauge cutting-edge core biopsy needle for the diagnosis of malignant lymphoma. AJR Am J Roentgenol 2003; 181:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/107\">",
"      G&oacute;mez-Rubio M, L&oacute;pez-Cano A, Rend&oacute;n P, et al. Safety and diagnostic accuracy of percutaneous ultrasound-guided biopsy of the spleen: a multicenter study. J Clin Ultrasound 2009; 37:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?33/34/34346/abstract/108\">",
"      McInnes MD, Kielar AZ, Macdonald DB. Percutaneous image-guided biopsy of the spleen: systematic review and meta-analysis of the complication rate and diagnostic accuracy. Radiology 2011; 260:699.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7134 Version 24.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-A1F0AAE071-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34346=[""].join("\n");
var outline_f33_34_34346=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14392127\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SPLENIC DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Normal splenic function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Hypersplenism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hyposplenism and asplenia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Splenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Splenic abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Splenic infarction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Splenic calcification and cysts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Calcification",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Cysts and pseudocysts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Splenic rupture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Traumatic splenic rupture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Atraumatic splenic rupture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7760030\">",
"      Splenic artery aneurysm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2090715\">",
"      SPLENIC SIZE AND PALPABILITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Palpation method",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Percussion of Traube's semilunar space",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Accuracy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Splenic imaging for size estimation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2074335\">",
"      - Splenic length in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      CAUSES OF SPLENOMEGALY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      General conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Splenic metastases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Common causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Massively enlarged spleen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      EVALUATION OF THE PATIENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Initial approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2090784\">",
"      - Unexplained splenomegaly",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Imaging studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      CBC and peripheral smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Additional approaches",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5011755\">",
"      - General considerations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Diagnostic splenectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5011770\">",
"      - Splenic aspiration/biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14392127\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14392135\">",
"      Splenic function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14392321\">",
"      Normal splenic size",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14392193\">",
"      Splenic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14392344\">",
"      Causes for an enlarged spleen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/7134\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7134|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/24/7566\" title=\"figure 1\">",
"      Splenic platelet pooling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7134|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/45/39638\" title=\"picture 1\">",
"      Howell-Jolly bodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/42/1703\" title=\"picture 2\">",
"      Sickle cell anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/56/25478\" title=\"picture 3\">",
"      Babesia microti thin smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/20/335\" title=\"picture 4A\">",
"      Plasmodium vivax thin smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/28/29120\" title=\"picture 4B\">",
"      P falciparum gametocyte",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/50/38694\" title=\"picture 5\">",
"      Schistocytes on peripheral smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/17/7449\" title=\"picture 6\">",
"      Toxic granulations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/10/15527\" title=\"picture 7\">",
"      Cold agglutinin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/24/1410\" title=\"picture 8\">",
"      Atypical lymphocytes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/43/30390\" title=\"picture 9\">",
"      Leukoerythroblastic blood smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/1/28\" title=\"picture 10\">",
"      Large granular lymphocytes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/63/17398\" title=\"picture 11\">",
"      Niemann Pick cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/18/14630\" title=\"picture 12\">",
"      Gaucher cells in marrow",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7134|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/7/32892\" title=\"table 1\">",
"      Causes reactive thrombocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/43/27324\" title=\"table 2\">",
"      Causes of splenomegaly",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38569?source=related_link\">",
"      Acute phase reactants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38213?source=related_link\">",
"      Anemias due to decreased red cell production",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/44/36554?source=related_link\">",
"      Approach to abdominal pain and the acute abdomen in pregnant and postpartum women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/19/15674?source=related_link\">",
"      Approach to the adult patient with thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/34/12840?source=related_link\">",
"      Approach to the child with an enlarged spleen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29511?source=related_link\">",
"      Approach to the patient with neutrophilia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19497?source=related_link\">",
"      Child abuse: Injuries of the thorax; abdomen; retroperitoneum; and pelvis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"./chronic-refractory-immune-thrombocytopenia-itp-in-adults?source=related_link\">",
"      Chronic refractory immune thrombocytopenia (ITP) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/63/6138?source=related_link\">",
"      Clinical aspects, diagnosis, and treatment of the sideroblastic anemias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/42/9895?source=related_link\">",
"      Clinical features and management of sepsis in the asplenic patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4247?source=related_link\">",
"      Clinical manifestations and diagnosis of Felty's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/63/1018?source=related_link\">",
"      Clinical manifestations and diagnosis of primary myelofibrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/55/14202?source=related_link\">",
"      Clinical manifestations and treatment of Epstein-Barr virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/62/12264?source=related_link\">",
"      Clostridial myonecrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23194?source=related_link\">",
"      Diagnostic approach to the patient with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9738?source=related_link\">",
"      Diagnostic approach to the patient with suspected polycythemia vera",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/30/16874?source=related_link\">",
"      Differential diagnosis of abdominal pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38313?source=related_link\">",
"      Evaluation of the peripheral blood smear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/57/3993?source=related_link\">",
"      Extrahepatic portal vein obstruction (portal vein thrombosis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/62/9194?source=related_link\">",
"      Extrinsic nonimmune hemolytic anemia due to mechanical damage: Fragmentation hemolysis and hypersplenism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/34/6697?source=related_link\">",
"      Extrinsic nonimmune hemolytic anemia due to systemic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/11/9402?source=related_link\">",
"      Gaucher disease: Pathogenesis, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/49/2842?source=related_link\">",
"      Hepatic manifestations of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/1/20506?source=related_link\">",
"      Hereditary spherocytosis: Clinical features; diagnosis; and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=related_link\">",
"      Infectious mononucleosis in adults and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=related_link\">",
"      Initial evaluation and management of blunt abdominal trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/62/5095?source=related_link\">",
"      Large granular lymphocyte leukemia in rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/42/4777?source=related_link\">",
"      Liver, spleen, and pancreas injury in children with blunt abdominal trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/54/1898?source=related_link\">",
"      Management of splenic injury in the adult trauma patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42170?source=related_link\">",
"      Overview of the clinical manifestations of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30535?source=related_link\">",
"      Pathogenesis of autoimmune hemolytic anemia: Cold agglutinin disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40650?source=related_link\">",
"      Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22777?source=related_link\">",
"      Pregnancy in women with pre-existing chronic liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36922?source=related_link\">",
"      Prognosis and treatment of primary myelofibrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7049?source=related_link\">",
"      Surgical management of splenic injury in the adult trauma patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6056?source=related_link\">",
"      The adaptive cellular immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27624?source=related_link\">",
"      The humoral immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"./treatment-and-prognosis-of-immune-thrombocytopenia-itp-in-adults?source=related_link\">",
"      Treatment and prognosis of immune thrombocytopenia (ITP) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/62/14313?source=related_link\">",
"      Treatment of autoimmune hemolytic anemia: Warm agglutinins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/39/7802?source=related_link\">",
"      Treatment of beta thalassemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35465?source=related_link\">",
"      Treatment of diuretic-resistant ascites in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/58/27561?source=related_link\">",
"      Treatment of echinococcosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_34_34347="Diagnostic criteria for diffuse panbronchiolitis";
var content_f33_34_34347=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F86536&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F86536&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for diffuse panbronchiolitis*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Noninvasive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Persistent cough, sputum, and exertional dyspnea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        History or current symptoms of chronic sinusitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bilateral, diffuse, small nodular shadows on a plain chest radiograph or centrilobular micronodules on chest CT images",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Coarse crackles",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        FEV",
"        <sub>",
"         1",
"        </sub>",
"        /FVC less than 70 percent and PaO",
"        <sub>",
"         2",
"        </sub>",
"        less than 80 mmHg (10.64 kPa)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Titer of cold agglutinins of 64 or greater",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Lung biopsy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lung biopsy showing inflammation centered on the respiratory bronchioles with a transmural infiltrate composed of lymphocytes, plasma cells, and distinctive lipid-laden \"foamy\" macrophages, also known as foam cells*",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     &nbsp;",
"    </p>",
"    <div class=\"footnotes\">",
"     FEV",
"     <sub>",
"      1",
"     </sub>",
"     /FVC: forced expiratory volume in one second/forced vital capacity; PaO",
"     <sub>",
"      2",
"     </sub>",
"     : arterial tension for oxygen.",
"     <br>",
"      * In regions where diffuse panbronchiolitis is endemic (eg, East Asia), a lung biopsy is not needed if the patient fulfills the first three criteria and at least two of the second three.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Kudoh S, Keicho N. Diffuse panbronchiolitis. Clin Chest Med 2012; 33:297.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34347=[""].join("\n");
var outline_f33_34_34347=null;
var title_f33_34_34348="Therapeutic exercise";
var content_f33_34_34348=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66164&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66164&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Types of therapeutic exercise",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type of exercise",
"       </td>",
"       <td class=\"subtitle1\">",
"        Description",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other_start\" colspan=\"2\">",
"        <strong>",
"         Flexibility exercises",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Static stretching",
"       </td>",
"       <td>",
"        Target muscle is stretched and held for 30 seconds or longer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Progressive velocity flexibility program",
"       </td>",
"       <td>",
"        Stretches muscles at higher velocities over time",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist_other_start\" colspan=\"2\">",
"        <strong>",
"         Strengthening exercises",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Isometric",
"       </td>",
"       <td>",
"        Muscle contracts without changing length",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Isotonic",
"       </td>",
"       <td>",
"        Muscle contracts against fixed resistance throughout its arc of motion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Isokinetic",
"       </td>",
"       <td>",
"        The speed of muscle contraction is constant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Concentric",
"       </td>",
"       <td>",
"        Contract or shorten muscles during exercise (eg, flexion phase of biceps curl)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Eccentric",
"       </td>",
"       <td>",
"        Controlled lengthening of the muscle against resistance (eg, extension phase of biceps curl)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Closed kinetic chain",
"       </td>",
"       <td>",
"        Distal extremity is fixed (eg, squat)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Open kinetic chain",
"       </td>",
"       <td>",
"        Distal extremity is not fixed (eg, straight leg raise in supine)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Functional",
"       </td>",
"       <td>",
"        Strengthen muscles in their position of normal use or function; generally replicate movements or patterns of movements used in sports activity",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Endurance exercises",
"        </strong>",
"       </td>",
"       <td>",
"        High-repetition, low-load",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist_other_start\" colspan=\"2\">",
"        <strong>",
"         Power exercises",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Plyometric activities (eg, bouncing, box jumps, rebounders, and explosive/ballistic exercise)",
"       </td>",
"       <td>",
"        Use the stretch-shortening cycle to get a greater force of contraction",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Agility drills",
"        </strong>",
"       </td>",
"       <td>",
"        Figure-eight running, zigzag running, shuttle running, carioca, retro running, cross-over cutting",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Anderson SJ. Principles of rehabilitation. In: Care of the Young Athlete, Sullivan JA, Anderson SJ (Eds). American Academy of Orthopedic Surgeons: American Academy of Pediatrics, Rosemont, IL 2000. p.267.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34348=[""].join("\n");
var outline_f33_34_34348=null;
var title_f33_34_34349="Neuropathic arthropathy in DM";
var content_f33_34_34349=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F74711&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F74711&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pathogenesis of diabetic neuropathic arthropathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 326px; height: 373px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34349=[""].join("\n");
var outline_f33_34_34349=null;
var title_f33_34_34350="Clear vs effluent rate CRRT";
var content_f33_34_34350=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F70337&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F70337&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 479px\">",
"   <div class=\"ttl\">",
"    Diffusive clearances for various solutes with Multiflow-100",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 459px; height: 329px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Figure showing diffusive clearances for several compounds with continuous venovenous hemodiafiltration (CVVHDF) performed at different effluent flow rates. With CVVHDF, equilibration between blood and dialysate is dependent upon the dialysate flow rate. For low molecular weight solutes, such as urea, there is near complete equilibration at low dialysate flow rates, with decreasing equilibration as dialysate flow increases. Over the commonly utilized range (500 mL/hour to 2500 mL/hour), the relationship between dialysate flow and diffusive clearance is nearly linear. However, for higher molecular weight species (eg, beta2-microglobulin), equilibration is limited, and clearance plateaus.",
"    <div class=\"footnotes\">",
"     Cr: creatinine; Ur: urate; P: phosphate; Q",
"     <sub>",
"      E",
"     </sub>",
"     , effluent flow rate.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Brunet, S, Leblanc, M, Geadah, D, et al. Diffusive and Convective Solute Clearances During Continuous Renal Replacement Therapy at Various Dialysate and Ultrafiltration Flow Rates. Am J Kidney Dis 1999; 34:486. Copyright &copy;1999 The National Kidney Foundation Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34350=[""].join("\n");
var outline_f33_34_34350=null;
var title_f33_34_34351="Callus PI";
var content_f33_34_34351=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F83519&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F83519&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Calluses on the hands",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 374px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This picture shows calluses on a person's hands. These form when something repeatedly rubs or presses on the skin. Over time, using gardening tools or sports equipment can cause calluses to appear on the hands.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_34_34351=[""].join("\n");
var outline_f33_34_34351=null;
